<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Mol Psychiatry</journal-id><journal-title-group><journal-title>Molecular Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">1359-4184</issn><issn pub-type="epub">1476-5578</issn><publisher><publisher-name>Nature Publishing Group UK</publisher-name><publisher-loc>London</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">39702695</article-id><article-id pub-id-type="pmc">PMC12092269</article-id>
<article-id pub-id-type="publisher-id">2870</article-id><article-id pub-id-type="doi">10.1038/s41380-024-02870-5</article-id><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>OXTR-mediated signaling in astrocytes contributes to anxiolysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3627-4754</contrib-id><name><surname>Meinung</surname><given-names>Carl-Philipp</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-2878-0761</contrib-id><name><surname>Boi</surname><given-names>Laura</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-6877-7102</contrib-id><name><surname>Pandamooz</surname><given-names>Sareh</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0003-3998-9330</contrib-id><name><surname>Mazaud</surname><given-names>David</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Gh&#x000e9;zali</surname><given-names>Gr&#x000e9;gory</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-5574-888X</contrib-id><name><surname>Rouach</surname><given-names>Nathalie</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-3911-5062</contrib-id><name><surname>Neumann</surname><given-names>Inga D.</given-names></name><address><email>inga.neumann@ur.de</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01eezs655</institution-id><institution-id institution-id-type="GRID">grid.7727.5</institution-id><institution-id institution-id-type="ISNI">0000 0001 2190 5763</institution-id><institution>Department of Behavioral and Molecular Neurobiology, </institution><institution>University of Regensburg, </institution></institution-wrap>Regensburg, Germany </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01n3s4692</institution-id><institution-id institution-id-type="GRID">grid.412571.4</institution-id><institution-id institution-id-type="ISNI">0000 0000 8819 4698</institution-id><institution>Stem Cells Technology Research Center, </institution><institution>Shiraz University of Medical Sciences, </institution></institution-wrap>Shiraz, Iran </aff><aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01mvzn566</institution-id><institution-id institution-id-type="GRID">grid.462887.7</institution-id><institution>Center for Interdisciplinary Research in Biology, Coll&#x000e8;ge de France, CNRS, INSERM, Universit&#x000e9; PSL, </institution><institution>Labex Memolife, </institution></institution-wrap>Paris, France </aff></contrib-group><pub-date pub-type="epub"><day>19</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="pmc-release"><day>19</day><month>12</month><year>2024</year></pub-date><pub-date pub-type="ppub"><year>2025</year></pub-date><volume>30</volume><issue>6</issue><fpage>2620</fpage><lpage>2634</lpage><history><date date-type="received"><day>19</day><month>10</month><year>2023</year></date><date date-type="rev-recd"><day>13</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>6</day><month>12</month><year>2024</year></date></history><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article&#x02019;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#x02019;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p></license></permissions><abstract id="Abs1"><p id="Par1">Astrocytes are an indispensable part of signal processing within the mammalian brain. Thus, the mode of action of a neuropeptide such as oxytocin (OXT) can only be fully understood considering this integral part of the CNS. Here, we show that OXT regulates astrocytic gene expression, intracellular signaling and specific proteins both in vitro and in vivo. This translates into rapid regulation of astroglial structural and functional properties including cytoskeletal plasticity, coverage of synapses and gap-junction coupling. At the molecular level, we identify the previously undescribed Sp1-Gem signaling cascade as the key driver for these cell type-specific OXT effects. Finally at the behavioral level, we found in vivo that OXT requires astrocytes to exert its well described anxiolytic properties within the hypothalamic paraventricular nucleus. Thus, our study points to OXT receptor-expressing&#x000a0;astrocytes as a critical component of the brain OXT system.</p></abstract><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Neuroscience</kwd><kwd>Molecular biology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001659</institution-id><institution>Deutsche Forschungsgemeinschaft (German Research Foundation)</institution></institution-wrap></funding-source><award-id>NE465/34-1</award-id><award-id>NE465/37-1</award-id><award-id>GRK2174</award-id><award-id>GRK2174</award-id><award-id>GRK2174</award-id><principal-award-recipient><name><surname>Meinung</surname><given-names>Carl-Philipp</given-names></name><name><surname>Boi</surname><given-names>Laura</given-names></name><name><surname>Neumann</surname><given-names>Inga D.</given-names></name></principal-award-recipient></award-group></funding-group><funding-group><award-group><funding-source><institution>European Research Council (consolidator grant #683154) Labex Memolife, Inserm and CNRS</institution></funding-source></award-group></funding-group><custom-meta-group><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#x000a9; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1" sec-type="introduction"><title>Introduction</title><p id="Par2">Due to its multiple physiological and behavioral functions, there has been a growing scientific interest in the nonapeptide oxytocin (OXT) and its cognate receptor (OXTR) over the last decades. The brain OXT system promotes various cognitive and social functions, and exerts robust anxiolytic and anti-stress effects (reviewed in refs. [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]), and is, thus, discussed as a potential therapeutic target for stress-related psychopathologies [<xref ref-type="bibr" rid="CR3">3</xref>&#x02013;<xref ref-type="bibr" rid="CR7">7</xref>]. In this context, a detailed understanding of the multiple modes of action of OXT at cellular level - both in neurons and astrocytes - is of high relevance. OXT effects are mainly mediated via the OXTR, a G protein-coupled receptor expressed in multiple cell types of the CNS, including astrocytes [<xref ref-type="bibr" rid="CR8">8</xref>, <xref ref-type="bibr" rid="CR9">9</xref>]. In neurons, OXT increases intracellular calcium (Ca<sup>2+</sup>) either from intracellular stores via activation of the protein kinase C (PLC) pathway or via activation of Ca<sup>2+</sup>influx [<xref ref-type="bibr" rid="CR10">10</xref>&#x02013;<xref ref-type="bibr" rid="CR13">13</xref>]. Further, Ca<sup>2+</sup>-dependent downstream mechanisms involve the activation of transcription factors via the mitogen-activated protein kinase (MAPK) signaling pathway and, thus, regulation of protein synthesis. Ca<sup>2+</sup> influx and activation of the MAPK pathway in hypothalamic neurons are essential for the anxiolytic effects of OXT [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR13">13</xref>].</p><p id="Par3">Although our understanding of the vital role of astrocytes in information processing within the brain and the regulation of behavior has expanded over the past decade [<xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR15">15</xref>], the effects of OXT on astrocytic cells, specifically on OXTR-coupled signaling and its resulting cellular and behavioral consequences, are rather poorly understood. Astrocytic activation by OXTR triggers various intracellular signaling pathways, such as PLC, MAPK and protein kinase A (PKA), potentially leading to modifications in astrocytic morphology and function [<xref ref-type="bibr" rid="CR16">16</xref>]. Pioneering studies observed a reversible retraction of glial processes from OXT neurons and, consequently, reduction in direct neuronal-glial juxtapositions and improved neuronal communication in the hypothalamus of lactating rat dams [<xref ref-type="bibr" rid="CR17">17</xref>]. These morphological adaptations may support physiological adaptations of OXT neurons in lactation, which display high activity and synchronicity [<xref ref-type="bibr" rid="CR18">18</xref>]. Thus, glial structural plasticity likely results in increased glutamate availability at the synaptic cleft [<xref ref-type="bibr" rid="CR19">19</xref>], elevated glutamate spillover from uncovered to neighbouring synapses [<xref ref-type="bibr" rid="CR20">20</xref>], and, consequently, a stronger depression of GABAergic transmission via activation of presynaptic mGluRs. However, whether these adaptations are due to direct actions of OXT on astrocytic cells, which express the OXTR in various brain regions [<xref ref-type="bibr" rid="CR16">16</xref>], is unknown.</p><p id="Par4">Over the past years several studies have revealed an unexpected role of astrocytes in the modulation of anxiety-like behavior, for example in the hypothalamic paraventricular nucleus (PVN), hippocampus and amygdala [<xref ref-type="bibr" rid="CR21">21</xref>&#x02013;<xref ref-type="bibr" rid="CR23">23</xref>]. However, a potential involvement of astrocytic OXTR signaling in behavioral regulation is rather unknown [<xref ref-type="bibr" rid="CR15">15</xref>]. Recently, OXTR-mediated modulation of the astro-neuronal network in the central amygdala has been shown to play a role in the anxiolytic effect of OXT in the context of chronic pain, as observed in an animal model of neuropathic pain [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par5">Here, we studied OXTR-mediated signaling and strictural plasticity of astrocytes in a cell type-specific way. We show that OXT causes rapid remodeling of astrocytes and simultaneous impairment of astrocytic networks. We further demonstrate that OXT exerts these effects via the previously undescribed Sp1-Gem signaling pathway, which marks it as a critical component of the cell type-specific response of astroglial cells to OXT. Finally, by selectively downregulating astrocytic OXTR signaling in vivo, we reveal that OXT requires direct binding to astrocytes to bring about its anxiolytic effect within the PVN.</p></sec><sec id="Sec2" sec-type="materials|methods"><title>Materials and methods</title><sec id="Sec3"><title>Animals</title><p id="Par6">Adult male Wistar rats (250&#x02013;300&#x02009;g; Charles River, Sulzfeld, Germany) were housed under standard laboratory conditions. After surgery, rats were single-housed for either five days (guide cannula implantations) or 3 weeks (viral microinfusions) before taking biological samples or behavioral testing.</p><p id="Par7">Experiments on mice were carried out using mice of wild-type C57BL/6j background, mice with glial conditional deletion of connexin 43 (Cx43) in astrocytes Cx43fl/fl:hGFAP-Cre (Cx43KO, provided by K. Willeke (University of Bonn, Germany) and constitutive knockout mice for Cx30. Experiments were performed in the light phase between 0800 and 1200&#x02009;h. They were approved by the government of Unterfranken, and performed in accordance with EU guideline 2010/63/EU and with the regulations of the local animal welfare committee (certificate A751901).</p></sec><sec id="Sec4"><title>Guide cannula implantations</title><p id="Par8">To study effects of intracerebroventricularly (<italic>icv</italic>) or locally applied synthetic OXT, rats underwent stereotaxic surgery for guide cannula implantation [<xref ref-type="bibr" rid="CR13">13</xref>] (for details, please see supplementary methods).</p></sec><sec id="Sec5"><title>Microinfusions</title><p id="Par9">For examination of acute effects of OXT on astrocytes, rats received a single <italic>icv</italic> infusion of either vehicle (Veh, sterile Ringer solution, pH 7.4, 5&#x02009;&#x000b5;l) or synthetic OXT (1 nmol/5&#x02009;&#x000b5;l; [<xref ref-type="bibr" rid="CR11">11</xref>]) via a 30&#x02009;G infusion cannula inserted into the implanted guide cannula.</p><p id="Par10">To induce astrocyte-specific knockdown of either <italic>Oxtr</italic> or <italic>Gem</italic> mRNA within the PVN, rats received bilateral intra-PVN microinfusions of respective AAV6-GFAP::shRNA constructs or a control vector expressing a scrambled RNA oligonucleotide via a pulled electrophysiology glass-pipette 21 days prior to behavioral testing (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1a</xref>; 280&#x02009;nl/PVN, 3.28&#x02009;&#x000d7;&#x02009;10<sup>13</sup> GC/ml, stereotaxic coordinates: AP: &#x02212;1.8&#x02009;mm bregma, ML: +/&#x02212;0.4&#x02009;mm, DV: +8.0&#x02009;mm; custom designed on <ext-link ext-link-type="uri" xlink:href="http://www.vectorbuilder.com">www.vectorbuilder.com</ext-link>). The transfected shRNAs were screened in primary rat cortical astrocytes for knockdown efficiency prior to use in vivo (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S2</xref>).</p><p id="Par11">For assessment of OXT-induced anxiolysis following astrocytic Gem or OXTR knockdown in the PVN, rats received single bilateral OXT infusions into the PVN (0.01 nmol/0.5&#x02009;&#x000b5;l, i.e. 100-fold lower amount of OXT in a smaller volume than <italic>icv</italic> infusion to prevent tissue damage) 21&#x02009;d after local virus infusion and 10&#x02009;min prior to behavioral testing [<xref ref-type="bibr" rid="CR11">11</xref>]. Correct infusion sites were verified by local ink infusion on 40-&#x000b5;m cryocut, Nissl-stained slices. Subsequently, 4 animals had to be excluded from statistical analysis due to misplaced infusions.</p></sec><sec id="Sec6"><title>Behavioral testing</title><p id="Par12">Rats were tested for anxiety-like behavior in the elevated plus-maze (EPM) and light-dark box (LDB), as previously described [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. To exclude biasing effects of manipulations on locomotive or exploratory behavior, the open field test (OF) was performed. Group sizes of n&#x02009;=&#x02009;6&#x02013;11 animals were chosen based on our previous studies on the anxiolytic effect of OXT [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>]. The investigator performing the behavioral test including behavioural analyses was blinded to pre-treatment and treatment. For quantification of times spent i) in open and closed arms of the EPM and ii) in the light box of the LDB, and the distance travelled in the OF EthoVision XT tracking software (Noldus Information Technology, Inc.) was used. As indicator of anxiety-related behaviour the percentage of time and the time spent in the open arms of the EPM and the light box of the LDB, respectively, are presented (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5g, h</xref>).</p></sec><sec id="Sec7"><title>Acute mouse hippocampal ex vivo slices</title><p id="Par13">Hippocampi from WT and Connexin knockout mice were fixed to a block of agar, on which slices (350&#x02009;&#x000b5;m) were prepared in a vibratome in oxygenized ACSF. Following bath application of either Veh (ACSF) or OXT (500&#x02009;nM) for 10&#x02009;min, slices were fixed in 4% PFA in PBS for 2&#x02009;h followed by 2&#x02009;h of blocking in PBS containing 2&#x02009;g gelatine/l and 1% Triton-X and stained (see <italic>immunohistochemistry)</italic> for morphological analysis, as well as 3D-reconstruction and determination of astrocyte-synapse spatial relationship (see below).</p></sec><sec id="Sec8"><title>Cells</title><sec id="Sec9"><title>Primary rat cortical astrocytes</title><p id="Par14">Cells isolated from cortices of newborn rat pups (post-natal day 1&#x02013;3) were used for all in vitro experiments on astrocytes (adapted from [<xref ref-type="bibr" rid="CR25">25</xref>]; for details see supplementary methods).</p></sec><sec id="Sec10"><title>H32 neuronal cells</title><p id="Par15">The immortalized fetal rat hypothalamic cell line H32 [<xref ref-type="bibr" rid="CR26">26</xref>] was cultured at 37&#x02009;&#x000b0;C and 5% CO2 in DMEM F-12 Ham (Sigma Aldrich; D8437) containing 10% FBS and 1% penicillin/streptomycin. Cells were regularly tested for mycoplasma contamination.</p></sec></sec><sec id="Sec11"><title>Transfection of astrocytes by electroporation</title><p id="Par16">In order to study the involvement of Cx43, Sp1 or Gem in astrocytic OXTR signaling, astrocytes were transfected with respective siRNA oligonucleotides (Cx43 (<italic>Gja1</italic>) siRNA, sc-60008, Santa Cruz Biotechnology, Dallas, USA; <italic>Sp1</italic> siRNA, Santa Cruz, sc-61895; <italic>Gem</italic> siRNA, Origene, Rockville, USA, SR507514) or a <italic>Gem</italic> overexpression plasmid (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1b</xref> VectorBuilder) by electroporation (Neon&#x02122; Transfection System, ThermoFisher; MPK5000).</p><p id="Par17">To screen for shRNA knockdown efficiency in vitro, astrocytes were transfected with a plasmid expressing a shRNA oligonucleotide under control of the long fragment of the <italic>hGFAP</italic> promoter targeted against <italic>Gem</italic> (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1c</xref>, VectorBuilder) or <italic>Oxtr</italic> (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1d</xref>, VectorBuilder) mRNAs. In case of siRNAs, a scrambled oligonucleotide (scrRNA) served as a control transfection, while a plasmid expressing solely the fluorescent reporter protein EGFP (Supplementary Fig.&#x000a0;<xref rid="MOESM1" ref-type="media">S1e</xref>, VectorBuilder) served as control for plasmid transfections.</p></sec><sec id="Sec12"><title>RNA isolation</title><p id="Par18">Cells were trypsinized at ~90% confluency, and RNA was isolated with 1&#x02009;ml peqGold&#x000ae; TriFast (peqLab, Erlangen, Germany). A subsequent DNA digestion was performed with a DNAse I system (ThermoFisher; EN0521). RNA quantity and quality were determined with a NanoDrop spectrophotometer (ThermoScientific, Waltham, USA).</p></sec><sec id="Sec13"><title>Reverse transcriptase PCR, endpoint PCR and quantitative PCR (qPCR)</title><p id="Par19">Reverse transcription was performed with Super Script IV (200U/&#x003bc;l; Life Technologies) system. Primers were designed using the NCBI primer Basic Local Alignment Search Tool (BLAST) software. Primer sequences are listed in Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S1</xref>. Primer pairs spanned exon-exon junctions to avoid amplification of genomic DNA (for details of endpoint PCR and qPCR-conditions, see supplementary methods).</p></sec><sec id="Sec14"><title>Protein extraction</title><p id="Par20">Proteins were either isolated from fresh brain tissue (PVN, amygdala, hippocampus) or cell culture. Pellets/punches were lysed in RIPA buffer (Sigma Aldrich) for 45&#x02009;min, and debris was removed by centrifugation (13,200&#x02009;&#x000d7;&#x02009;<italic>g</italic>, 4&#x02009;&#x000b0;C). Protein concentration was measured with a colorimetric BCA protein assay kit (Pierce <sup>TM</sup> BCA Protein Assay Kit, Thermo Scientific) and quantified using an optical density reader (FLUOstar OPTIMA, BMG Labtech, Ortenberg, Germany).</p></sec><sec id="Sec15"><title>SDS-PAGE and Western blot</title><p id="Par21">Proteins were separated and quantified as previously described [<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR28">28</xref>]. For details see supplementary methods.</p></sec><sec id="Sec16"><title>Immunocytochemistry</title><p id="Par22">Astrocytes (14&#x02009;d post-enrichment) were seeded in four-chamber glass slides (7&#x02009;&#x000d7;&#x02009;10<sup>5</sup> cells/chamber; Corning; 354104). After 1&#x02009;h of serum starvation, cells were stimulated with varying concentrations of OXT (1&#x02009;nM - 1&#x02009;&#x000b5;M) for the full duration of 10&#x02009;min or 3&#x02009;h. Cells were fixed with 4% PFA for 10&#x02009;min and blocked for 30&#x02009;min (0.1% TritonX-100, 1% FBS, 10% normal goat serum in PBS). Next, specimen was incubated with primary antibodies (Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S2</xref>) diluted in PBS containing 0.5% TritonX-100 and 3.3% FBS for 2&#x02009;h at RT. Appropriate secondary antibodies (Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S2</xref>) were applied for 2&#x02009;h at RT in the dark. Slides were covered with ProLong&#x000ae; Gold DAPI (Cell Signaling Technology, Princeton, USA; cs8961).</p></sec><sec id="Sec17"><title>Immunohistochemistry</title><p id="Par23">Ten or 20&#x02009;min after <italic>icv</italic> OXT rats were transcardially perfused with 4% PFA in PBS. Brains were harvested and post-fixed in 4% PFA for 3&#x02009;h followed by cryo-protection in 30% sucrose for 2 days and snap-freezing in isopentane. Frontal 40-&#x000b5;m cry-sections were prepared, blocked in PBS containing 2% goat serum and 1% TritonX-100 for 1&#x02009;h, and incubated with primary antibody (Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S3</xref>) at 4&#x02009;&#x000b0;C overnight. Appropriate secondary antibodies (Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S3</xref>) were added for 2&#x02009;h, and sections were mounted with ProLong&#x000ae; Gold DAPI (Cell Signaling).</p></sec><sec id="Sec18"><title>Gap-junctional intercellular communication (GJIC)</title><p id="Par24">To investigate the effects of OXT on astrocytic intercellular coupling, scrape loading dye transfer experiments were performed. 8&#x02009;&#x000d7;&#x02009;10<sup>5</sup> primary astrocytes (14 days in vitro) were seeded in poly-D-lysine coated 35-mm TC dishes (Corning; CLS3294) 2&#x02009;d prior to the experiments. After 1&#x02009;h of serum starvation, OXT (1nM&#x02013;1&#x02009;&#x000b5;M) or AVP (1nM-1&#x000b5;M) was added to the medium for the full duration of differing timespans (5&#x02013;180&#x02009;min). To investigate the underlying signaling cascades, cells were pre-incubated with either 1&#x02009;&#x000b5;M U0126 (MAP kinase inhibition), 10&#x02009;&#x000b5;M G&#x000f6;6983 (PKC inhibition), 1&#x02009;&#x000b5;M L368,889 (OXTR antagonism), 1&#x02009;&#x000b5;M carbenoxolone (gap-junction inhibition; [<xref ref-type="bibr" rid="CR29">29</xref>], Sigma Aldrich; C4790) or Veh (Ringer&#x02019;s solution) 1&#x02009;h prior to OXT stimulation. Dishes were rinsed three times with Ca<sup>2+</sup>-free PBS to prevent uncoupling of the cells. Next, 1&#x02009;ml of warmed (37&#x02009;&#x000b0;C) lucifer yellow (1&#x02009;mg/ml in Ca<sup>2+</sup>-free PBS, Sigma Aldrich; L0259) or, in case of EGFP expressing cells, biocytin (1&#x02009;mg/ml in Ca<sup>2+</sup>-free PBS, Sigma Aldrich; B4261) was added, and three cuts were made through the cell layer with a rounded surgical blade, allowing the fluorescent solution to diffuse within the astrocytic network. After 10&#x02009;min of incubation, cells were fixed with 4% PFA. For Biocytin experiments, an AlexaFluor594-conjugated streptavidin (ThermoFisher; S32356) was used to visualize Biocytin diffusion. The fluorescence signal was viewed using an epifluorescence microscope (Leica dm5000b), and images of each cut were taken. The fluorescent dye spread area was quantified with ImageJ software (Version 1.52e). Results were regularly cross-validated by an independent investigator blinded to the treatment.</p></sec><sec id="Sec19"><title>Bioimaging and image analysis</title><p id="Par25">For all experiments, microscopy and image analysis settings were kept identical within one experiment. In vitro experiments were replicated at least three times.</p><sec id="Sec20"><title>Morphological analysis in vitro, in vivo and ex vivo</title><p id="Par26">To assess effects of OXT and its downstream effectors on astrocytic morphological features, astrocytes were stained for GFAP and DAPI, and images were taken with either Leica SP8 (for in vitro and in vivo) or SP6 (for ex vivo) CLSM. In case of cultured cells, five pictures throughout one culture chamber were acquired per treatment condition and analyzed with ImageJ (Supplementary Fig.&#x000a0;<xref rid="MOESM3" ref-type="media">S3a</xref>). For in vivo and ex vivo analyses, three z-sections per animal and brain region (30&#x02009;&#x000b5;m, 0.5&#x02009;&#x000b5;m/z-section, 1024 &#x000d7; 1024) were acquired and analyzed with ImageJ (Supplementary Fig.&#x000a0;<xref rid="MOESM3" ref-type="media">S3b</xref>). Results were regularly cross-validated by an independent investigator blinded to the treatment.</p></sec><sec id="Sec21"><title>3D-reconstruction of GFP-expressing astrocytes</title><p id="Par27">To analyze OXT-induced changes in volume and surface area of astrocytes, mice received an unilateral intra-hippocampal (CA1 region) infusion of vector plasmid solution containing AAV2/5-GFAP::GFP in PBS (titer 1&#x02009;&#x000d7;&#x02009;10<sup>13</sup> GC/ml,1&#x02009;&#x000b5;l). After 14 days, acute hippocampal slices (350&#x02009;&#x000b5;m) were prepared as described. 3D-reconstruction was performed using IMARIS software (Version 9.3, Bitplane AG, Z&#x000fc;rich, Switzerland). Two astrocytes per z-section were randomly selected (Supplementary Fig.&#x000a0;<xref rid="MOESM4" ref-type="media">S4a</xref>), and a region of interest (ROI) was created in 3D around these cells (Supplementary Fig.&#x000a0;<xref rid="MOESM4" ref-type="media">S4b, c</xref>). Next, a 3D object was generated within these ROIs (Supplementary Fig.&#x000a0;<xref rid="MOESM4" ref-type="media">S4d, e</xref>), allowing quantification of both cellular surface and volume.</p></sec><sec id="Sec22"><title>Determination of astrocyte-synapse spatial relationship by STED</title><p id="Par28">To assess OXT effects on synaptic spatial relationships, STED nanoscopy was performed on acute ex vivo slice preparations using a custom-built STED microscope (Abberrior/Scientifica) [<xref ref-type="bibr" rid="CR30">30</xref>]. Synaptic distance to the closest astrocytic element was quantified with a Fiji-Plugin (provided by Philippe Mailly, CIRB imaging facility, College de France, Paris) only including synapses that a) showed no wider distance than 300&#x02009;nm between pre-and postsynaptic element, and b) contained Homer1/VGlut1 fluorescence maxima in both, deconvolved confocal images and STED images.</p></sec><sec id="Sec23"><title>Colocalization studies</title><p id="Par29">To assess the degree of Cx43 localization at cell/cell-contacts, the tight-junction protein ZO1 was used as a marker for points of intercellular contact [<xref ref-type="bibr" rid="CR31">31</xref>]. The number of Cx43/ZO1-immunoreactive punctae was determined manually to ensure inclusion of points solely located at cellular contact zones.</p></sec><sec id="Sec24"><title>Intensity measurements and determination of above threshold cells</title><p id="Par30">For immunofluorescence intensity measurements and maxima quantification, images were taken with a Leica SP8 CLSM (63x objective, 16-Bit, 1024&#x02009;&#x000d7;&#x02009;1024 pixels) and analyzed with ImageJ. Following background subtraction, a ROI was manually generated around cells of interest and fluorescence intensity was measured. Determination of above threshold cells was accomplished by use of the find maxima function of ImageJ on a background subtracted single image (in vitro experiments) or a sum z-projection (in vivo experiments; 30&#x02009;&#x000b5;m, 0.5&#x02009;&#x000b5;m/z-section, 1024&#x02009;&#x000d7;&#x02009;1024). Above threshold cells were defined as single cells marked by DAPI staining displaying at least one maximum of the fluorescence of interest.</p></sec></sec><sec id="Sec25"><title>Statistical analysis</title><p id="Par31">For statistical analysis, GraphPadPrism (V.8, GraphPad Software, San Diego, USA) was used. Data were first tested for normal distribution by Shapiro&#x02013;Wilks-test. In case of normal distribution, statistical hypothesis testing was carried out by two-tailed Student&#x02019;s <italic>t</italic> test (comparison of two treatments/group), one-way (factor: treatment; comparison of more than two treatments) or two-way (factors: pre-treatment and treatment; comparison of pre-treated groups with following treatment) ANOVA, followed by Bonferroni post-hoc analysis, when appropriate. For non-normally distributed data, statistical hypothesis testing was carried out by two-tailed Mann&#x02013;Whitney U-test (comparison of two treatments/group) or Kruskal&#x02013;Wallis-test (comparison of more than two treatments) followed by Dunn-Bonferroni post-hoc analysis, when appropriate. All data are presented as mean absolute or relative values +/&#x02212;SEM or median&#x02009;+&#x02009;min/max, and significance was accepted at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs. the respective Veh group for i) Student&#x02019;s <italic>t</italic> test, Bonferroni-post-hoc analysis of one-way ANOVA, Mann&#x02013;Whitney U-test and Dunn-Bonferroni post-hoc analysis of Kruskal&#x02013;Wallis test or ii) vs. the respective control group pre-treated with either Veh or scrRNA for Bonferroni post-hoc analysis of two-way ANOVA.</p></sec></sec><sec id="Sec26" sec-type="results"><title>Results</title><sec id="Sec27"><title>Effects of OXT on astrocytic signaling cascades and proteins in vitro and in vivo</title><p id="Par32">We focused on brain regions, such as the hypothalamic PVN, hippocampus and amygdala, and signaling cascades, which have been previously linked to neuronal OXTR activation [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR32">32</xref>], as well as on targets preferentially or exclusively expressed in astrocytes. Our experiments revealed acute effects of OXT on components of various signaling pathways including MAPK signaling (pCREB, pERK1/2 and pERK5), cytoskeleton-associated pathways (Gem, Sp1, beta-tubulin and ROCK1) and pathways related to intercellular connectivity (Cx30 and Cx43). In detail, in primary astrocytes (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>), exposure to OXT for 10&#x02009;min increased the cytoskeleton-related proteins pEzrin/Thr567, beta-Tubulin, ROCK1 and the endogenous ROCK-inhibitor Gem, while pMYPT/Thr696 and GFAP were reduced. The astrocytic glutamate transporter EAAT2 was unaffected. Furthermore, OXT exposure increased the phosphorylation level of the signaling proteins pCreb/Ser133, pAkt/Thr308, pERK1/2, and pERK5/Thr218/Tyr220, while decreasing peEF/Thr56 phosphorylation. No changes were observed for pp38, pAMPK/Thr172, pJNK/Thr183/Thr185 and pcamKII/Thr286. Furthermore, OXT-exposure elevated phosphorylation levels of gap-junction proteins (pCx43/Ser368, pCx43/Ser279, pCx43/P1, and pCx43/P2).<fig id="Fig1"><label>Fig. 1</label><caption><title>OXT affects astrocytic proteins in vitro and in vivo, and impairs gap-junctional intercellular communication (GJIC) in primary rat cortical astrocytes in a MEK, PKC and OXTR-dependent manner.</title><p><bold>a</bold> Heatmap of percentage changes in protein or protein phosphorylation levels in primary astrocytes following 10-min exposure to 500&#x02009;nM OXT (upper panel), and in brain tissue punches taken from the PVN, hippocampus and amygdala 10&#x02009;min or 20&#x02009;min after <italic>icv</italic> administration of OXT (1 nmol/5&#x02009;&#x000b5;l) (lower panel). Downregulations are colored in blue, while upregulations are colored in red. <bold>b</bold> Representative images of streptavidin staining visualizing the distance of biocytin diffusion and, thus, reflecting GJIC within the astrocytic network. Exposure of primary astrocytes to either OXT (500&#x02009;nM) or the gap-junction blocker carbenoxolone (CBX, 1&#x02009;&#x000b5;M) impaired relative GJIC compared to vehicle (Veh) treatment. Scale bar = 100&#x02009;&#x000b5;m. <bold>c</bold> Dose-dependent effects of OXT (applied for 10&#x02009;min) on relative GJIC in primary astrocytes (treatment F<sub>4</sub>,<sub>73</sub>&#x02009;=&#x02009;6.847, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus Veh; **<italic>p</italic>&#x02009;=&#x02009;0.001 for 10&#x02009;nM; ***<italic>p</italic>&#x02009;=&#x02009;0.0004 for 1000&#x02009;nM). <bold>d</bold> Relative GJIC of astrocytes pre-treated for 1&#x02009;h with either Veh, the MAP kinase inhibitor U0126 (1&#x02009;&#x000b5;M), the PKC inhibitor G&#x000f6;6983 (10&#x02009;&#x000b5;M) or the OXTR antagonist L368,889 (1&#x02009;&#x000b5;M) prior to OXT exposure (500&#x02009;nM, 15&#x02009;min) or AVP exposure (1&#x02009;&#x000b5;M, 15&#x02009;min) (interaction: F<sub>3</sub>,<sub>62</sub>&#x02009;=&#x02009;5.574, <italic>p</italic>&#x02009;=&#x02009;0.002; *<italic>p</italic>&#x02009;=&#x02009;0.01 Veh/OXT vs. Veh/Veh treatment). <bold>e</bold> Relative GJIC in astrocytic cultures after treatment with CBX (t<sub>15</sub>&#x02009;=&#x02009;14.75, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.0001 versus Veh). <bold>f</bold> Representative immunocytochemical images of astrocytes stained for Cx43 (green), the tight-junction protein ZO1 (red) and DAPI (blue) showing lower levels of Cx43/ZO1 colocalization in OXT- compared with Veh-treated cells. White arrows indicate points of Cx43/ZO1 colocalization. <bold>g</bold> Dose-dependent effects of OXT (15&#x02009;min) on Cx43 localization at cell-cell contacts (treatment F<sub>5,36</sub>&#x02009;=&#x02009;8.810, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 versus Veh; *100&#x02009;nM: <italic>p</italic>&#x02009;=&#x02009;0.050, ***500&#x02009;nM: <italic>p</italic>&#x02009;=&#x02009;0.0002, **1&#x02009;&#x000b5;M: <italic>p</italic>&#x02009;=&#x02009;0.003). <bold>h</bold> Effect of differing exposure times to OXT (500&#x02009;nM) on Cx43 localization at cell-cell contacts (treatment F<sub>5,36</sub>&#x02009;=&#x02009;6.077, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 vs. basal (t&#x02009;=&#x02009;0); **<italic>p</italic>&#x02009;=&#x02009;0.005 for 10&#x02009;min; *<italic>p</italic>&#x02009;=&#x02009;0.024 for 15&#x02009;min; **<italic>p</italic>&#x02009;=&#x02009;0.003 for 180&#x02009;min). <bold>i</bold> Impact of OXT (500&#x02009;nM, 15&#x02009;min) or AVP (1&#x02009;&#x000b5;M, 15&#x02009;min) on Cx43/Zo1 colocalization following pre-treatment with either Veh, U0126, G&#x000f6;6983 or L368,889 (see legend in D) (interaction: F<sub>3,46</sub>&#x02009;=&#x02009;5.267, <italic>p</italic>&#x02009;=&#x02009;0.003; **<italic>p</italic>&#x02009;=&#x02009;0.008 for Veh/OXT vs. Veh/Veh; ** <italic>p</italic>&#x02009;=&#x02009;0.001 U0126/OXT vs Veh/Veh). Data represent mean absolute or relative values +/&#x02212;SEM.</p></caption><graphic xlink:href="41380_2024_2870_Fig1_HTML" id="d33e758"/></fig></p><p id="Par33">The alterations in protein and protein phosphorylation levels observed in vivo were time and brain region-dependent (see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Particularly, in line with the effects of OXT on cortical astrocytic cytoskeleton- and gap junction-related proteins in vitro, <italic>icv</italic> OXT increased levels of Cx30, pCx43/Ser368 and Gem within the PVN after 10&#x02009;min, while downregulating EAAT2 and unphosphorylated Cx43. Elevation of Cx30, pCx43/Ser368 and Gem remained observable after 20&#x02009;min, whereas EAAT2 and unphosphorylated Cx43 levels recovered to control levels. Within the hippocampus, <italic>icv</italic> OXT resulted in elevated quantities of Cx30 and pCx43/Ser368 after 10&#x02009;min, decreased quantities of Cx43 after 10&#x02009;min to 20&#x02009;min, and in downregulation of the astrocytic glutamate transporter EAAT1 at 20&#x02009;min. Within the amygdala, <italic>icv</italic> OXT increased Cx30 and EAAT1, while decreasing Gem levels after 10&#x02009;min. After 20&#x02009;min, upregulated GFAP and decreased quantities of EAAT2 were found. For a summary of all examined target proteins and detailed statistics see Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref> and Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S4</xref>.</p></sec><sec id="Sec28"><title>Effects of OXT on the expression of selected astrocytic genes</title><p id="Par34">Based on the OXT-induced changes in astrocytic protein levels, we analysed the dynamics of corresponding mRNA expression in primary cortical astrocytes (Supplementary Fig.&#x000a0;<xref rid="MOESM5" ref-type="media">S5</xref> and Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S5</xref>). Briefly, after 10&#x02009;min, OXT tended to decrease mRNA levels of Cx30 (<italic>Gjb6</italic>) and Cx26 (<italic>Gjb2)</italic> (Supplementary Fig.&#x000a0;<xref rid="MOESM5" ref-type="media">S5a</xref>), whereas Cx43 (<italic>Gja1</italic>) mRNA was not affected. After 30&#x02009;min, the trend of decreased <italic>Gjb2</italic> expression observed at 10&#x02009;min became significant. Simultaneously, an increased <italic>Gja1</italic> as well as <italic>Gem</italic> expression was detected, while EAAT2 (<italic>Slc1a2)</italic> expression remained unchanged (Supplementary Fig.&#x000a0;<xref rid="MOESM5" ref-type="media">S5b</xref>). Contrary to a shorter exposure, 180&#x02009;min of OXT stimulation caused a decrease in <italic>Gja1</italic> expression (Supplementary Fig.&#x000a0;<xref rid="MOESM5" ref-type="media">S5c</xref>), while <italic>Gjb2</italic> mRNA recovered to control levels. Last, <italic>Gjb6</italic> expression was still lowered after 180&#x02009;min.</p></sec><sec id="Sec29"><title>Effects of OXT on distribution of astrocytic gap-junction proteins and intercellular connectivity</title><p id="Par35">Based on the OXT-induced downregulation of astrocytic gap-junction subunits both at mRNA and protein level, we next tested, whether OXT affects gap-junctional intercellular communication (GJIC) using dye-spread assays (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b</xref>; [<xref ref-type="bibr" rid="CR33">33</xref>]). The broad-range gap-junction inhibitor carbenoxolone served as a positive control (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1b, e</xref>; [<xref ref-type="bibr" rid="CR29">29</xref>]). In an initial dose-response experiment, OXT acutely impaired GJIC at doses of 10&#x02009;nM and 1&#x02009;&#x000b5;M (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1c</xref>). OXT-treated cells showed impaired GJIC by around 20%, while this effect was prevented by OXTR/MEK/PKC inhibitors/antagonists (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>). The related nonapeptide arginine vasopressin (AVP) had no effect on GJIC (100&#x02009;nM; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1d</xref>).</p><p id="Par36">To visualize the impact of OXT on astrocytic interconnectivity on a single cell level, we co-stained the most abundant astrocytic gap-junction protein Cx43 with the tight-junction protein ZO1 as marker for cell-cell contacts (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1f</xref>). OXT at 100&#x02009;nM, 500&#x02009;nM and 1&#x02009;&#x000b5;M reduced Cx43 localization at cell-cell contacts by 35&#x02013;60% (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1g</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM5" ref-type="media">S5d</xref>) beginning at 10&#x02009;min post-application (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1h</xref>). A longer exposure time (180&#x02009;min) similarly reduced Cx43 localization.</p><p id="Par37">To investigate the underlying signaling cascades of reduced Cx43 localization at cell-cell contacts by OXT, cells were pre-treated as described for GJIC experiments prior to OXT stimulation (500&#x02009;nM; 15&#x02009;min). OXT-treated cells displayed less Cx43 localization at cell-cell contacts, and this effect was PKC and OXTR-dependent, but not MEK- dependent (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1i</xref>). AVP had no effect (100&#x02009;nM; Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1i</xref>).</p></sec><sec id="Sec30"><title>OXT-induced changes in astrocytic cytoskeletal dynamics in vitro and in vivo and astrocyte-neuron spatial relationships</title><p id="Par38">The modulation of neuronal communication by astrocytes highly depends on the spatial relationship of astrocytes and neuronal synapses, critically set by the astrocytic cytoskeleton. Since we revealed changes of several proteins associated with cytoskeletal dynamics, we examined OXT effects on the cytoskeleton of astrocytes in vitro and in vivo. In an initial dose-response experiment (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2a, b</xref>), 500&#x02009;nM OXT caused a rapid elongation of GFAP+ astrocytic processes after 10&#x02009;min in cultured cells. To investigate the underlying signaling mechanisms, cells were pre-treated as described above prior to 10&#x02009;min of OXT exposure. In the subsequent analysis of primary process length and number, OXT-treated cells showed an increased length of primary processes by around 25%, an effect blocked by pre-administration of either the OXTR antagonist, or the MEK or PKC inhibitors (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). Differences in process number (Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">S6a</xref>) were found with OXT causing a ~30% increase in primary process number that was MEK, PKC, as well as OXTR-dependent. Similar to gap-junction experiments, AVP was without effect (100&#x02009;nM; Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">S6c</xref>). OXT stimulation for a prolonged period (180&#x02009;min) produced comparable results (Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">S6b&#x02013;d</xref>).<fig id="Fig2"><label>Fig. 2</label><caption><title>OXT alters the astrocytic morphological phenotype in a PKC, MEK and OXTR-dependent manner and astrocyte-neuron spatial relationships in vitro (in primary cortical rat astrocytes) and in vivo.</title><p><bold>a</bold> Representative images of primary astrocytes stained for GFAP (green) and DAPI (blue) showing OXT-induced morphological alterations. Scale bar = 20&#x02009;&#x000b5;m. <bold>b</bold> Dose-dependent effect of 10-min exposure to OXT on the length of the longest primary process in vitro (F<sub>4,539</sub>&#x02009;=&#x02009;2.760, <italic>p</italic>&#x02009;=&#x02009;0.027; *<italic>p</italic>&#x02009;=&#x02009;0.016 for 500&#x02009;nM OXT vs. Veh). <bold>c</bold> Effect of 10-min OXT or AVP exposure on process length of primary astrocytes following pre-treatment with either Veh, U0126, G&#x000f6;6983 or L368,889 (for details see legend to Fig.<xref rid="Fig1" ref-type="fig">1</xref>; interaction: F<sub>3,646</sub>&#x02009;=&#x02009;4.480, <italic>p</italic>&#x02009;=&#x02009;0.004; **<italic>p</italic>&#x02009;=&#x02009;0.008 Veh/Veh vs. Veh/OXT. <bold>d</bold>, <bold>e</bold> in vitro effects of 180-min OXT exposure (<bold>d</bold>) on astrocytic F-actin levels reflected by phalloidin immunofluorescence (t<sub>13</sub>&#x02009;=&#x02009;3.225, **<italic>p</italic>&#x02009;=&#x02009;0.007 vs. Veh), and (<bold>e)</bold> on phospho(Ser19)-myosin-light-chain-kinase (pMLC/Ser19) immunofluorescence (t<sub>12</sub>&#x02009;=&#x02009;3.136, **<italic>p</italic>&#x02009;=&#x02009;0.009 vs. Veh). <bold>f</bold> Representative images of PVN astrocytes (GFAP; green) co-stained with neurophysin (OXT; red) and DAPI (blue) in rats 10&#x02009;min after <italic>icv</italic> Veh or OXT (1 nmol/5&#x02009;&#x000b5;l). White arrows mark points of GFAP/neurophysin (OXT) colocalization indicating astrocyte-neuron contacts. Scale bar = 10&#x02009;&#x000b5;m. <bold>g</bold>&#x02013;<bold>i</bold> Effects of <italic>icv</italic> infusion of OXT on primary process length after 10&#x02009;min (<bold>g</bold>; t<sub>10</sub>&#x02009;=&#x02009;3.48, **<italic>p</italic>&#x02009;=&#x02009;0.006), primary process number (H; t<sub>10</sub>&#x02009;=&#x02009;2.47, *<italic>p</italic>&#x02009;=&#x02009;0.033) and GFAP/OXT-colocalization (<bold>I</bold>; t<sub>10</sub>&#x02009;=&#x02009;3.09, * <italic>p</italic>&#x02009;=&#x02009;0.011) within the rat PVN. <bold>j</bold> Representative confocal microscopy image of a GFP-expressing mouse hippocampal astrocyte. Scale bar = 10&#x02009;&#x000b5;m. <bold>k</bold> Representative 3D reconstructions of astrocytes created from Veh or OXT (500&#x02009;nM, 10&#x02009;min) -treated acute mouse hippocampal slices. Scale bar = 10&#x02009;&#x000b5;m. <bold>l</bold> Assessment of cellular surface area from 3D reconstructed astrocytes (t<sub>20</sub>&#x02009;=&#x02009;3.302, **<italic>p</italic>&#x02009;=&#x02009;0.004). <bold>m</bold> Assessment of cellular volume from 3D-reconstructed astrocytes (t<sub>20</sub>&#x02009;=&#x02009;2.155, *<italic>p</italic>&#x02009;=&#x02009;0.046). <bold>n</bold> Representative confocal microscopy image of a GFP-expressing mouse hippocampal astrocyte. Scale bar = 10&#x02009;&#x000b5;m. White dotted box indicates inlay for middle panel. Inlay includes deconvolved confocal image of astrocytic element (GFP; red), as well as deconvolved STED-images of pre-synaptic (VGlut1; Magenta) and post-synaptic (Homer1; green) markers. Scale bar for inlays = 1&#x02009;&#x000b5;m. Right panel displays representative astrocyte processes in their spatial relationship to pre- and post-synaptic elements from slices treated with either Veh or OXT. <bold>o</bold> Average synapse/astrocyte distance per analyzed inlay (t<sub>15</sub>&#x02009;=&#x02009;3.003, **<italic>p</italic>&#x02009;=&#x02009;0.009). Data represent mean absolute or relative values +/&#x02212;SEM.</p></caption><graphic xlink:href="41380_2024_2870_Fig2_HTML" id="d33e1035"/></fig></p><p id="Par39">Since cellular process formation and elongation are indicators of a dampened activity of the RhoA/ROCK pathway [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>], and considering that our protein analyses revealed an OXT-induced increase in the endogenous RhoA/ROCK inhibitor Gem as well as a decrease of the ROCK phosphorylation-target pMYPT/Thr696, F-actin (Phalloidin) and phospho(Ser19)-myosin-light-chain-kinase, fluorescent intensity measurements were used as additional indirect markers of RhoA/ROCK activity (Supplementary Figs.&#x000a0;<xref rid="MOESM6" ref-type="media">S6e</xref>; [<xref ref-type="bibr" rid="CR37">37</xref>]). Indeed, prolonged OXT stimulation (500&#x02009;nM, 180&#x02009;min) induced a decrease in F-actin stress fibres (Supplementary Figs.&#x000a0;<xref rid="MOESM6" ref-type="media">2d, S6e</xref>) and pMLC/Ser19 levels (Supplementary Figs.&#x000a0;<xref rid="MOESM6" ref-type="media">2e, S6e</xref>), both indicative of a dampened RhoA/ROCK activity. Taken together, OXT rapidly modulates the cytoskeleton of astrocytes in vitro.</p><p id="Par40">To validate these effects in vivo, PVN and hippocampal (CA1 region) astrocytes were examined 10&#x02009;min after <italic>icv</italic> OXT for changes in cellular morphology and resulting neuron-astrocyte spatial relationships. Corroborating in vitro experiments, OXT caused GFAP+ astrocytic process elongation (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f, g</xref>) and ramification (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f, h</xref>) within the PVN, leading to an increased astrocytic coverage of OXT neurons (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2f, i</xref>). The total amount of PVN GFAP+ cells remained unchanged (Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">S6f</xref>).</p><p id="Par41">As GFAP is a cytoskeleton protein not expressed throughout the entire astrocytic cell, we next used a viral vector-based strategy to express GFP under the promoter of the <italic>hGFAP</italic> gene (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2j</xref>). 3D-reconstruction (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2k</xref>) revealed an increase in astrocyte surface (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2l</xref>) and volume (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2m</xref>) after acute (10&#x02009;min) OXT exposure. Co-staining with pre-/ post-synaptic markers together with STED nanoscopy (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2n</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM6" ref-type="media">S6g</xref>) revealed an OXT-induced increase in the spatial relationship between astrocytes and excitatory synapses after 10&#x02009;min of bath application in acute hippocampal slices (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2o</xref>), suggesting an effect of OXT-induced morphological remodeling on neuronal communication.</p></sec><sec id="Sec31"><title>The involvement of the small GTPase Gem in astrocytic OXT effects</title><p id="Par42">Considering the OXT-induced upregulation of the endogenous ROCK-inhibitor Gem and simultaneously observed dampened activity of the RhoA/ROCK pathway, we next tested the hypothesis that Gem is central in conveying the effects of OXT on astrocytes. Therefore, we knocked down Gem in vitro (Supplementary Fig.&#x000a0;<xref rid="MOESM7" ref-type="media">S7a</xref>), which prevented OXT-induced process elongation. siRNA/OXT-treated cells even displayed shortened processes compared to scrRNA/Veh-treated cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>). OXT did induced ramification in scrRNA control cells by statistical trend, as <italic>Gem</italic> siRNA/OXT cells displayed significantly fewer primary processes than scrRNA/OXT-treated cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3b</xref>). We could further exclude the possibility that the cytoskeleton of <italic>Gem</italic> siRNA cells is uncapable to respond to stimuli: treatment of <italic>Gem</italic> siRNA cells with the ROCK-inhibitor y-27632 (1&#x02009;&#x000b5;M for 30&#x02009;min; [<xref ref-type="bibr" rid="CR38">38</xref>]) as positive control resulted in a process elongation (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3c</xref>). Furthermore, the observed OXT-induced breakdown of F-actin stress-fibres might also partially be Gem-dependent, as knockdown of Gem blunted this effect (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3d</xref>). Notably, OXT induced ROCK-activity solely in Gem knockdown astrocytes, as assessed by pMYPT/Thr696 phosphorylation levels (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3e</xref>), which might explain the observed retraction of processes in <italic>Gem</italic> siRNA/OXT cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>). Similar to OXT effects on the cytoskeleton, we found OXT-induced effects on astrocytic gap-junctions to be Gem-dependent, as Gem knockdown prevented OXT-induced (i) impairment of GJIC (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3f</xref>), and (ii) reduction of Cx43 localization at cell-cell contacts (Supplementary Fig.&#x000a0;<xref rid="MOESM7" ref-type="media">S7b</xref>).<fig id="Fig3"><label>Fig. 3</label><caption><title>Gem is required and sufficient for the effects of OXT on astrocytes in vitro.</title><p><bold>a</bold>, <bold>b</bold> Gem siRNA knockdown prevents OXT-induced prolongation of primary processes (<bold>a</bold>; interaction: F<sub>1,405</sub>&#x02009;=&#x02009;10.58, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; **<italic>p</italic>&#x02009;=&#x02009;0.008 scRNA/Veh vs. scRNA/OXT; *<italic>p</italic>&#x02009;=&#x02009;0.016 siRNA/OXT vs. scrRNA/Veh) and increase in primary process number (<bold>b</bold>; interaction: F<sub>1,491</sub>&#x02009;=&#x02009;3.204, <italic>p</italic>&#x02009;=&#x02009;0.074; <italic>p</italic>&#x02009;=&#x02009;0.09 for scRNA/Veh vs. scRNA/OXT; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 siRNA-pretreated vs. scRNA-pretreated/OXT astrocytes). Cells were transfected with either <italic>Gem</italic> siRNA or a control oligonucleotide (scrRNA) 48&#x02009;h prior to OXT (500&#x02009;nM, 10&#x02009;min). Representative Western blot bands of successful knockdown (scRNA/Veh vs. siRNA/Veh) are shown below. <bold>c</bold> Length of longest primary process after exposure to the ROCK-inhibitor y-27632 (1&#x02009;&#x000b5;M, 30&#x02009;min) in primary astrocytes transfected with <italic>Gem</italic> siRNA (<italic>U</italic>&#x02009;=&#x02009;5936, **<italic>p</italic>&#x02009;=&#x02009;0.009). <bold>d</bold> Phalloidin/F-actin immunofluorescence after Gem knockdown and subsequent OXT exposure (500&#x02009;nM, 10&#x02009;min; interaction: F<sub>1,37</sub>&#x02009;=&#x02009;0.588, <italic>p</italic>&#x02009;=&#x02009;0.448; **<italic>p</italic>&#x02009;=&#x02009;0.003 scrRNA/Veh vs. scrRNA/OXT, <italic>p</italic>&#x02009;=&#x02009;0.063 siRNA/Veh vs. siRNA/OXT). <bold>e</bold> Relative phosphorylation of MYPT at Thr696 following Gem knockdown and subsequent OXT stimulation (interaction: F<sub>1,12</sub>&#x02009;=&#x02009;15.42, <italic>p</italic>&#x02009;=&#x02009;0.006; **<italic>p</italic>&#x02009;=&#x02009;0.003 siRNA/Veh vs. siRNA/OXT). Representative Western blot bands are shown below. <bold>f</bold> Absolute area of lucifer yellow diffusion (dye spread experiments) after Gem knockdown and subsequent OXT exposure (interaction: F<sub>1,59</sub>&#x02009;=&#x02009;9.424, <italic>p</italic>&#x02009;=&#x02009;0.003; *<italic>p</italic>&#x02009;=&#x02009;0.041 scrRNA/Veh vs. scrRNA/OXT). <bold>g</bold> Gem protein levels in primary astrocytes transfected with either EGFP control plasmid or Gem overexpression (OE) plasmid indicating successful Gem OE after 72&#x02009;h (t<sub>8</sub>&#x02009;=&#x02009;3.137, *<italic>p</italic>&#x02009;=&#x02009;0.014). <bold>h</bold>&#x02013;<bold>j</bold> Effects of Gem OE on the cytoskeleton of astrocytes reflected by increased process length (<bold>h</bold>; interaction: F<sub>1,354</sub>&#x02009;=&#x02009;23.64, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 EGFP/Veh vs. Gem OE/Veh and vs. EGFP/OXT) and process number (<bold>J;</bold>
<italic>U</italic>&#x02009;=&#x02009;1881, **<italic>p</italic>&#x02009;=&#x02009;0.002). Representative images taken from EGFP-expressing control or Gem OE cells stained for DAPI (blue) and GFAP (red) (<bold>I</bold>; scale bar&#x02009;=&#x02009;50&#x02009;&#x000b5;m). <bold>k</bold> Representative images of phalloidin staining in EGFP vs. Gem OE -transfected cells. Scale bar = 20&#x02009;&#x000b5;m. <bold>l</bold> Phalloidin/F-actin immunofluorescence intensity in EGFP vs. Gem OE -transfected cells (t<sub>14</sub>&#x02009;=&#x02009;4.467, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001). <bold>m</bold> pMYPT/Thr696 phosphorylation levels reflecting ROCK activity in EGFP vs. Gem OE -expressing cells (t<sub>8</sub>&#x02009;=&#x02009;2.792, *<italic>p</italic>&#x02009;=&#x02009;0.026). <bold>n</bold> Representative images of scrape-loading dye transfer experiments in EGFP vs. Gem OE -transfected cells. Scale bar = 100&#x02009;&#x000b5;m; biocytin-AlexaFluor594 streptavidin staining pseudocolored in green. <bold>o</bold> Degree of GJIC in EGFP vs. Gem OE -transfected cells followed by stimulation with OXT (500&#x02009;nM, 10&#x02009;min) (interaction: F<sub>1,44</sub>&#x02009;=&#x02009;7.450, <italic>p</italic>&#x02009;=&#x02009;0.009; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 EGFP/Veh vs. Gem OE/Veh and vs. Gem OE/OXT; *<italic>p</italic>&#x02009;=&#x02009;0.018 EGFP/Veh vs. EGFP/OXT). Data represent mean relative or absolute values +/&#x02212;SEM for normally distributed data and median +/&#x02212;min/max values for non-normally distributed data.</p></caption><graphic xlink:href="41380_2024_2870_Fig3_HTML" id="d33e1323"/></fig></p><p id="Par43">In a gain-of-function approach, we next tested whether overexpression (OE) of Gem (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3g</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM7" ref-type="media">S7c&#x02013;e</xref>) mimics the effect of OXT on the astrocytic cytoskeleton. Indeed, Gem OE caused significant process elongation and ramification (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3h&#x02013;j</xref>) to a similar extent as OXT, and OXT had no further add-on effect in Gem OE cells compared to control EGFP expressing cells. Again, similar to OXT, Gem OE elicited significant stress fibre breakdown (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3k, l</xref>), and a strong reduction in ROCK-activity as assessed by quantification of pMYPT/Thr696 phosphorylation levels (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3m</xref>).</p><p id="Par44">In GJIC experiments, Gem OE impaired astrocyte network connectivity with no add-on effect of OXT (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3n, o</xref>). On a molecular level, Gem OE altered Cx43 phosphorylation states (Supplementary Fig.&#x000a0;<xref rid="MOESM7" ref-type="media">S7f, g</xref>) and decreased Cx43 (<italic>Gja1</italic>) mRNA (Supplementary Fig.&#x000a0;<xref rid="MOESM7" ref-type="media">S7h</xref>) analogously to OXT stimulations. Taken together, Gem is required and sufficient for the effects of OXT on astrocytic morphology and intercellular connectivity.</p></sec><sec id="Sec32"><title>Involvement of astrocytic connexin 43 in OXT-induced cytoskeletal remodeling</title><p id="Par45">To further assess the link between OXT-induced regulation of astrocytic gap-junction proteins and altered cytoskeletal dynamics, acute hippocampal slices prepared from Cx30KO or Cx43KO mice, as well as WT mice (C57BL/6) were treated with 500&#x02009;nM OXT for 10&#x02009;min. Similar to experiments in rats, OXT increased process length, process number and domain area in slices from WT and Cx30KO mice (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4a&#x02013;c</xref>), but not from Cx43KO mice (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4d</xref>). This suggests a selective involvement of Cx43 in OXT-induced cytoskeletal dynamics of astrocytes.<fig id="Fig4"><label>Fig. 4</label><caption><title>Cx43, but not Cx30, is involved in OXT-induced alterations of the cytoskeleton of astrocytes.</title><p><bold>a</bold> Representative images taken from mouse acute hippocampal slices treated with either 500&#x02009;nM OXT or Veh for 10&#x02009;min. Scale bar = 10&#x02009;&#x000b5;m. <bold>b</bold>&#x02013;<bold>d</bold> Domain area, process length and process number of astrocytes in acute hippocampal slice preparations from either wildtype (WT; <bold>b</bold>), Cx30 knockout (<bold>c</bold>) or Cx43 knockout (<bold>d</bold>) mice treated with OXT or Veh (treatment: domain area: t<sub>14</sub>&#x02009;=&#x02009;2.016, <italic>p</italic>&#x02009;=&#x02009;0.063 WT; t<sub>19</sub>&#x02009;=&#x02009;3.900, ***<italic>p</italic>&#x02009;=&#x02009;0.001 Cx30KO; process length: <italic>U</italic>&#x02009;=&#x02009;6, *<italic>p</italic>&#x02009;=&#x02009;0.02 WT; t<sub>22</sub>&#x02009;=&#x02009;2.183, *<italic>p</italic>&#x02009;=&#x02009;0.04 Cx30KO; process number: t<sub>13</sub>&#x02009;=&#x02009;2.321, *<italic>p</italic>&#x02009;=&#x02009;0.037 WT; t<sub>19</sub>&#x02009;=&#x02009;3.456, **<italic>p</italic>&#x02009;=&#x02009;0.003 Cx30KO). <bold>e</bold> Validation of successful Cx43 knockdown in rat primary astrocytes by means of immunoblotting (t<sub>7</sub>&#x02009;=&#x02009;4.319, **<italic>p</italic>&#x02009;=&#x02009;0.004). Representative Western blot bands are shown below. <bold>f</bold> Quantification of longest primary process in cells transfected with either <italic>Gja1</italic> siRNA or a control oligonucleotide (scrRNA) and subsequent administration of OXT (interaction: F<sub>1,680</sub>&#x02009;=&#x02009;3.617, <italic>p</italic>&#x02009;=&#x02009;0.058; **<italic>p</italic>&#x02009;=&#x02009;0.01 scrRNA/Veh vs. scrRNA/OXT). <bold>g</bold> No effect of Cx43 knockdown on Gem protein quantities. Representative Western blot bands are shown below. <bold>h</bold> Effect of Cx43 knockdown on phosphorylation of Ezrin/Thr576 reflecting an increase in active Ezrin (t<sub>11</sub>&#x02009;=&#x02009;2.438, *<italic>p</italic>&#x02009;=&#x02009;0.033). Representative Western blot bands are shown below. <bold>i</bold> Correlation of Cx43 level in <italic>Gja1</italic> siRNA transfected cells with Ezrin phosphorylation (<italic>p</italic>&#x02009;=&#x02009;0.046, r<sup>2</sup>&#x02009;=&#x02009;0.582). Data represent mean relative or absolute values +/&#x02212;SEM.</p></caption><graphic xlink:href="41380_2024_2870_Fig4_HTML" id="d33e1470"/></fig></p><p id="Par46">Consistent with these data, Cx43 knockdown in vitro prevented OXT-induced elongation of astroglial processes (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4e, f</xref>). Transfection with Cx43 siRNA did not affect the total amount of Gem (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4g</xref>), but increased the phosphorylated (i.e., active) levels of the Gem effector Ezrin (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4h</xref>), indicating that Ezrin (and likely Gem) is negatively regulated by Cx43 levels (Fig.&#x000a0;<xref rid="Fig4" ref-type="fig">4i</xref>).</p></sec><sec id="Sec33"><title>Regulation of Gem by OXT at the genomic level</title><p id="Par47">To reveal the transcription factor mediating the upregulation of Gem by OXT, we used a publically available database (AliBaba 2.1; <ext-link ext-link-type="uri" xlink:href="http://gene-regulation.com/pub/programs/">http://gene-regulation.com/pub/programs/</ext-link> alibaba2/index.html) to predict transcription factor binding sites within the promoter region of <italic>Gem</italic>. Here, Sp1 posed the highest number of binding sites (Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S6</xref>; 12 predicted sites vs. 1-2 for other transcription factors).</p><p id="Par48">Based on above in silico analysis and the finding that OXT increased Sp1 protein levels (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>), we hypothesized that Sp1 controls Gem expression and conveys OXT-induced Gem-dependent alterations to the cytoskeleton of astrocytes. In-vitro knockdown of Sp1 (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5</xref>a, Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8a</xref>) prevented OXT-induced process elongation (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>). Similar to the OXT-induced retraction of processes following Gem knockdown (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a</xref>), OXT decreased process length in the Sp1 knockdown group. Importantly, knockdown of Sp1 led to a decrease of <italic>Gem</italic> mRNA expression (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5c</xref>) and prevented OXT-induced upregulation of Gem (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5d</xref>, Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8b</xref>). However, Sp1 knockdown did not affect <italic>Oxtr</italic> mRNA levels (Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8c</xref>), excluding the possibility of nonresponsive OXTR-coupled pathways caused by secondary effects on Oxtr expression.<fig id="Fig5"><label>Fig. 5</label><caption><title>The transcription factor Sp1 conveys OXT-induced Gem expression, and astrocytic OXTR signaling within the PVN is required for the local anxiolytic effect of OXT.</title><p><bold>a</bold> Successful knockdown of Sp1 by transfection of primary astrocytes with <italic>Sp1</italic> siRNA assessed by immunoblotting (t<sub>4</sub>&#x02009;=&#x02009;4.548, *<italic>p</italic>&#x02009;=&#x02009;0.01 at 24&#x02009;h, and t<sub>4</sub>&#x02009;=&#x02009;4.548, *<italic>p</italic>&#x02009;=&#x02009;0.009 at 48&#x02009;h siRNA vs. scrRNA). Representative bands are shown below. <bold>b</bold> Effects of Sp1 knockdown on OXT-induced prolongation of the longest primary process. Primary astrocytes were transfected with either <italic>Sp1</italic> siRNA or a control oligonucleotide (scrRNA) 48&#x02009;h hrs prior to OXT exposure (500&#x02009;nM, 10&#x02009;min). (Interaction: F<sub>1,1106</sub>&#x02009;=&#x02009;16.51, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; *<italic>p</italic>&#x02009;=&#x02009;0.012 scrRNA/Veh vs. scrRNA/OXT; *<italic>p</italic>&#x02009;=&#x02009;0.031 for siRNA/Veh vs. siRNA/OXT). <bold>c</bold> Effects of Sp1 knockdown on <italic>Gem</italic> mRNA expression (t<sub>9</sub>&#x02009;=&#x02009;2.818, *<italic>p</italic>&#x02009;=&#x02009;0.02 vs. scrRNA). <bold>d</bold> Representative images from <italic>Sp1</italic> siRNA or scrRNA-transfected astrocytes subsequently exposed to OXT (500&#x02009;nM, 10&#x02009;min) and stained for GFAP (green), DAPI (blue) and Gem (red) showing Sp1-dependency of OXT-induced Gem expression. Scale bar = 10&#x02009;&#x000b5;m. Quantification of above threshold (Gem+) cells was defined as single cells marked by DAPI/GFAP staining displaying at least one maximum of above threshold Gem fluorescence (interaction: F<sub>1,832</sub>&#x02009;=&#x02009;22.32, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 scrRNA/Veh vs. scrRNA/OXT; scale bar = 30&#x02009;&#x000b5;m). <bold>e</bold> Targeting of astrocytes within the rat PVN with AAV6-GFAP::shRNA vectors to induce either <italic>Oxtr</italic> (<italic>Oxtr</italic> shRNA) or <italic>Gem</italic> (<italic>Gem</italic> shRNA) knockdown in a cell type-specific manner. Illustration adapted from Paxinos and Watson (2006) to show anatomical structures of the rat PVN. Representative image taken from the PVN of rats that received bilateral microinfusions of either <italic>Oxtr</italic>- or <italic>Gem-</italic> knockdown vector (280&#x02009;nl per side) 21&#x02009;d before. Successful transfection is indicated by the expression of the fluorescent reporter mCherry, while cell-type specificity is indicated by double positive immunostaining for mCherry and GFAP (scale bar = 20&#x02009;&#x000b5;m). <bold>f</bold> Quantification of perturbance and specificity of AAV6-GFAP::shRNA constructs (n&#x02009;=&#x02009;3). <bold>g</bold> Percentage of time spent in open arms of the EPM of rats pre-treated with either <italic>Oxtr</italic> shRNA or <italic>Gem</italic> shRNA for astrocyte-specific knockdown of OXTR or Gem, or with scrRNA within the left and right PVN, and locally infused with either Veh or OXT (0.01 nmol/0.5&#x02009;&#x000b5;l) 10&#x02009;min prior testing (genotype F<sub>2</sub>,<sub>37</sub>&#x02009;=&#x02009;0.443, <italic>p</italic>&#x02009;=&#x02009;0.639; treatment F<sub>1</sub>,<sub>37</sub>&#x02009;=&#x02009;0.021, <italic>p</italic>&#x02009;=&#x02009;0.885, *<italic>p</italic>&#x02009;=&#x02009;0.045 scr/Veh vs. scr/OXT, *<italic>p</italic>&#x02009;=&#x02009;0.030 shRNA/Veh vs. shRNA/OXT; n&#x02009;=&#x02009;6&#x02013;11/group). <bold>h</bold> Time spent in the light box of the LDB of rats treated as described above (g), (genotype F<sub>2</sub>,<sub>41</sub>&#x02009;=&#x02009;3,965, <italic>p</italic>&#x02009;=&#x02009;0.027; treatment F<sub>1</sub>,<sub>41</sub>&#x02009;=&#x02009;6.165, <italic>p</italic>&#x02009;=&#x02009;0.017, *<italic>p</italic>&#x02009;=&#x02009;0.016 scr/Veh vs. scr/OXT; n&#x02009;=&#x02009;6&#x02013;11/group). Data represent mean relative or absolute values +/&#x02212;SEM.</p></caption><graphic xlink:href="41380_2024_2870_Fig5_HTML" id="d33e1681"/></fig></p></sec><sec id="Sec34"><title>Involvement of astrocytic OXTR signaling in the acute anxiolytic properties of OXT</title><p id="Par49">Among the many behavioural effects of OXT is its established anxiolytic action within the PVN after local infusion of synthetic OXT [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR39">39</xref>, <xref ref-type="bibr" rid="CR40">40</xref>]. To study the behavioral relevance of astrocytic OXTR signaling and its downstream effector Gem within the PVN, we established AAV6-GFAP::shRNA-mCherry vectors providing an astrocyte-specific knockdown of OXTR or Gem (Supplementary Figs.&#x000a0;<xref rid="MOESM1" ref-type="media">S1</xref>a, &#x000a0;<xref rid="MOESM2" ref-type="media">S2</xref>). Transfection specificity (ratio mCherry+/GFAP+ cells; 94.0%) and perturbance (ratio GFAP+/mCherry+ cells; 84.3%) was analyzed three weeks post-infection within the PVN (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5e&#x02013;f</xref>). For assessment of OXT-induced anxiolysis following astrocytic Gem or OXTR knockdown, rats received bilateral OXT infusions 21&#x02009;d after virus infusions (Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8d</xref>) and 10&#x02009;min prior to assessment of anxiety-related behavior in the EPM and LDB.</p><p id="Par50">In both tests for anxiety-related behavior, we confirmed the acute anxiolytic effect of OXT within the PVN shown before [<xref ref-type="bibr" rid="CR28">28</xref>], as scrRNA/OXT rats showed significantly increased percentage of time spent in the open arms (EPM; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5g</xref>) and increased time spent in the light area (LDB; Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5h</xref>) and entered these areas more often (data not shown) than scrRNA/Veh controls. In contrast, these effects were absent in both shRNA/Oxtr- or shRNA/Gem knockdown rats. No group differences in locomotion (EPM, OF) were found (Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8f, g</xref>). These results indicate that astrocytic OXTR signaling within the PVN is required for the local anxiolytic effect of OXT.</p></sec><sec id="Sec35"><title>Differential regulation of the Sp1-Gem-ROCK axis in neuronal cells</title><p id="Par51">Since OXT exerts contrary effects on the cytoskeleton of neuronal cells [<xref ref-type="bibr" rid="CR41">41</xref>], i.e., a retraction of neurites, we examined whether OXT differentially regulates the Sp1-Gem-ROCK signaling axis in H32 neuronal cells. Indeed, in contrast to astrocytes, stimulation of H32 neurons with OXT (100&#x02009;nM, 180&#x02009;min) revealed an OXT-induced increase in ROCK1 protein level and ROCK activity and a decrease in Gem and Sp1 levels (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6a&#x02013;d</xref>; Supplementary Fig.&#x000a0;<xref rid="MOESM8" ref-type="media">S8g</xref> for Gem protein levels after 10&#x02009;min of OXT exposure). OXT-induced retraction of neurites was prevented in cells pre-treated with the ROCK-inhibitor y-27632 (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6e</xref>).<fig id="Fig6"><label>Fig. 6</label><caption><title>The regulation of Gem by OXT is polarized depending on cell type.</title><p>Effect of OXT (100&#x02009;nM, 180&#x02009;min) on protein levels of Gem (<bold>a</bold>; t<sub>13</sub>&#x02009;=&#x02009;3.700, **<italic>p</italic>&#x02009;=&#x02009;0.003), ROCK1 (<bold>b</bold>; t<sub>14</sub>&#x02009;=&#x02009;3.744, **<italic>p</italic>&#x02009;=&#x02009;0.002), pMYPT/Thr696 (<bold>c</bold>; t<sub>12</sub>&#x02009;=&#x02009;3.244, **<italic>p</italic>&#x02009;=&#x02009;0.007) and Sp1 (<bold>d</bold>; t<sub>12</sub>&#x02009;=&#x02009;8.751, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001) in H32 neurons assessed by immunoblotting. Representative bands are shown below. <bold>e</bold> Effects of OXT on neurite length of H32 cells pre-treated with either Veh or the ROCK-inhibitor y-27632 (interaction: F<sub>1,1884</sub>&#x02009;=&#x02009;7.396, <italic>p</italic>&#x02009;=&#x02009;0.007, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 Veh/Veh vs. Veh/OXT). <bold>f</bold>, <bold>g</bold> Representative images of hippocampal astrocytes (GFAP; green) co-stained with Gem (red) and DAPI (blue) in rats that received either Veh or OXT <italic>icv</italic>. Quantification of above threshold (Gem+) cells was defined as single cells marked by DAPI/GFAP (Gem+/GFAP+; t<sub>10</sub>&#x02009;=&#x02009;2.771, *<italic>p</italic>&#x02009;=&#x02009;0.020) or DAPI/absence of GFAP (Gem+/GFAP-; t<sub>10</sub>&#x02009;=&#x02009;2.606, *<italic>p</italic>&#x02009;=&#x02009;0.029) staining displaying at least one maximum of above threshold Gem fluorescence. Data represent mean relative or absolute values +/&#x02212;SEM.</p></caption><graphic xlink:href="41380_2024_2870_Fig6_HTML" id="d33e1811"/></fig></p><p id="Par52">To support the idea of this cell type-specific effect, the cellular distribution of Gem was analyzed within the hippocampus of <italic>icv</italic> OXT-treated rats (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6f</xref>). In line with protein analyses (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>, Supplementary Table&#x000a0;<xref rid="MOESM10" ref-type="media">S4</xref>), OXT did not alter the total amount of Gem (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6g</xref>). However, an analysis of the distribution in astrocytes (GFAP+) vs. non-astrocytic cells (GFAP&#x02212;) revealed an OXT-induced increase of Gem-positive (Gem+) astrocytes and a simultaneous decrease of Gem-expressing non-astrocytic cells, supporting the idea of a cell type-dependent polarized regulation of Gem by OXT and consequent differing outcomes in cytoskeletal responses.</p></sec></sec><sec id="Sec36" sec-type="discussion"><title>Discussion</title><p id="Par53">In this study, we describe the effects of OXT on astrocytic gene expression, intracellular signaling as well as astrocyte-specific proteins both in vitro and in vivo. We further show that OXT induces rapid alterations in the cytoskeletal plasticity of astrocytes, gap-junction coupling and astrocyte-neuron spatial relationships. Specifically, we identify the previously undescribed Sp1-Gem signaling cascade as being central to these cell type-specific effects of OXT. Targeted downregulation of astrocytic OXTR signaling in the rat PVN finally provides evidence that OXT requires direct binding to astrocytes to exert its local anxiolytic effect. Thus, our study establishes astrocytes as a critical component involved in the behavioural effects of the brain OXT system.</p><p id="Par54">Our initial analysis of OXTR-coupled pathways demonstrates the high responsiveness of astrocytes to OXT and points towards Ca<sup>2+</sup> and EGFR as important nodes of astrocytic OXTR signaling. This is in line with previous studies, in which OXT elicited rapid dose-dependent Ca<sup>2+</sup> release from intracellular stores in cultured hypothalamic astrocytes [<xref ref-type="bibr" rid="CR8">8</xref>] and an increase in nuclear pERK1/2 in astrocytes of acute SON slice preparations [<xref ref-type="bibr" rid="CR42">42</xref>], respectively. These identified downstream activation patterns (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>), in general, compare well to OXT effects in neuronal and myometrial cells [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>], for review see [<xref ref-type="bibr" rid="CR1">1</xref>]. However, we also report on astrocyte-specific responses to OXT, such as the lack of CamKII activation [<xref ref-type="bibr" rid="CR10">10</xref>] and a decrease in the activity of ROCK ([<xref ref-type="bibr" rid="CR45">45</xref>]).</p><p id="Par55">An important finding is that OXT rapidly impairs astrocytic intercellular coupling via specific signaling proteins, such as MAPKs and ERKs (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1</xref>). Previous studies demonstrated that PKC and MAPK signaling regulate gap-junction permeability, internalization, and degradation in astrocytes via C-terminal phosphorylation at Ser368 and MAPK-induced Ser279/Ser282 phosphorylation of Cx43 [<xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR47">47</xref>], both of which we found to be induced by OXT. The transient recovery of Cx43 localization at cell/cell contacts after 30&#x02009;min of OXT exposure might be due to the increase in Cx43 (<italic>Gja1</italic>) mRNA expression detected at this timepoint and might reflect a compensatory feedback mechanism. However, prolonged stimulation with OXT mimicked the effect of acute exposure on GJIC and was accompanied by decreased <italic>Gja1</italic> expression at this timepoint, indicating a manifestation of the inhibitory effect on gap-junctions, when astrocytes are exposed to OXT for longer periods of time. The fact that OXT induces a dynamic and isoform-specific expression of connexin-coding genes (Fig. S5) underlines its capacity to inhibit intercellular connectivity. Alterations in the interconnectivity of astroglial networks produce profound effects on synaptic transmission and plasticity on multiple levels. First, metabolites required at sites of high neuronal activity are partially trafficked via astroglial gap-junctions, which have been shown to undergo activity-dependent reshaping to meet this demand [<xref ref-type="bibr" rid="CR48">48</xref>, <xref ref-type="bibr" rid="CR49">49</xref>]. Second, both potassium and glutamate reuptake efficiency are enhanced in areas of coupled astrocytes, pointing towards an inhibitory role of astroglial networks [<xref ref-type="bibr" rid="CR50">50</xref>]. Last, gliotransmission induced by neuronal activity can additionally be triggered at distal synapses by information spread via astroglial networks and, thereby, lead to secondary activation of neurons [<xref ref-type="bibr" rid="CR51">51</xref>&#x02013;<xref ref-type="bibr" rid="CR53">53</xref>]. In case of Cx30, it controls synapse invasion [<xref ref-type="bibr" rid="CR54">54</xref>], synaptic glutamate clearance [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR55">55</xref>] and cellular polarity [<xref ref-type="bibr" rid="CR56">56</xref>]. Thus, the acute upregulation of astrocytic Cx30 by OXT could cause a less efficient glutamate uptake akin to the implications of OXT-induced EAAT2 downregulation. Our results demonstrate the regulation of astrocytic gap-junctions and their forming proteins by OXT, potentially facilitating excitatory transmission. However, the consequences on neuronal communication should be addressed by future work.</p><p id="Par56">Since astrocytes modulate and support neuronal functions via facilitated diffusion of signaling molecules, ions or metabolites, the spatial arrangement and distance between astrocytic processes and neuronal structures are of functional importance [<xref ref-type="bibr" rid="CR57">57</xref>]. This relationship is critically set by the astrocytic cytoskeleton [<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR59">59</xref>]. We revealed that OXT alters the expression of proteins associated with cytoskeletal dynamics, such as beta-tubulin, elements of the ROCK-pathway and GFAP (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>). Consequently, we investigated OXT effects on astrocyte morphology and astrocyte-neuron spatial relationships. Indeed, OXTR mediates cytoskeletal remodeling in vitro and in vivo, conveyed via PKC and, to a lesser extent, MEK1/2 signaling. Specifically, we could show that OXT induces process elongation and ramification both in astrocytic cultures as well as within the rat PVN, leading to an increased astrocytic coverage of OXT neurons (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2</xref>). These results are generally supporting OXT as a regulator of cellular morphology in a cell type-dependent manner [<xref ref-type="bibr" rid="CR41">41</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#x02013;<xref ref-type="bibr" rid="CR63">63</xref>]. Interestingly, it has repeatedly been observed that both hyperosmotic stress [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>] and elevated levels of OXT in the hypothalamic SON and PVN, e.g., during periods of heightened OXT activity such as lactation [<xref ref-type="bibr" rid="CR17">17</xref>, <xref ref-type="bibr" rid="CR63">63</xref>], led to the retraction of astrocytic processes and increased neuronal-somata contacts, indicating OXT&#x02019;s impact on the astrocyte-neuron spatial relationship [<xref ref-type="bibr" rid="CR42">42</xref>]. However, the OXT-induced elongation and ramification of astrocytes we have observed in vitro and in male rats as well as the increased coverage of PVN OXT neurons following OXT-exposure (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2i</xref>) contradict the retraction of astroglial processes observed in the hypothalamic SON in lactation [<xref ref-type="bibr" rid="CR63">63</xref>]. This discrepancy might be due to the variations in the mobility of major astrocytic branches, visualized by GFAP, compared to their fine, GFAP-negative, distal processes. To overcome this limitation, we expressed GFP in astrocytes followed by 3D-reconstruction and assessment of astrocytic synaptic coverage. We found a greater distance between synapses and GFP-labeled astrocytic elements in OXT-treated hippocampal slices, which is consistent with the decreased astroglial coverage described in the SON [<xref ref-type="bibr" rid="CR63">63</xref>]. Notably, in the same acute slices, we could reproduce elongation and ramification of GFAP-positive branches, confirming the above described difference between major and fine branches. In the SON, the reduced astroglial synaptic coverage caused by OXT was reported to increase glutamate availability [<xref ref-type="bibr" rid="CR19">19</xref>] and spillover to neighbouring synapses, facilitating excitatory transmission [<xref ref-type="bibr" rid="CR20">20</xref>]. Importantly, the OXT-induced alterations in astrocytic morphology were highly specific as AVP, the related peptide had no effect, supporting findings in the SON [<xref ref-type="bibr" rid="CR63">63</xref>].</p><p id="Par57">Interestingly, recent studies also describe that OXT induces neurite retraction in hypothalamic H32 cells [<xref ref-type="bibr" rid="CR41">41</xref>], influencing cytoskeletal proteins involved in neurite outgrowth [<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR67">67</xref>], which was shown to be mediated via inhibition of the calcium voltage-gated channels [<xref ref-type="bibr" rid="CR68">68</xref>]. This aspect further underlines OXT&#x000b4;s potential impact on synaptic spatial relationships. The observed changes in these relationships may be due to a concerted, synergistic, effect of OXT on neuronal and astrocyte dynamics under the control of a differential regulation of the ROCK-pathway (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>).</p><p id="Par58">ROCK signaling is involved in various cytoskeleton-associated cellular processes like contractility or migration, and OXT activates myometrial ROCK to increase uterine contractility [<xref ref-type="bibr" rid="CR45">45</xref>]. Here, we describe that OXT effects on astrocytic cytoskeletal dynamics and GJIC are mediated by Gem, an endogenous inhibitor of the RhoA/ROCK pathway [<xref ref-type="bibr" rid="CR69">69</xref>, <xref ref-type="bibr" rid="CR70">70</xref>]. Hallmarks of astrocytic RhoA/ROCK activation are retraction or loss of processes, whereas decreased RhoA/ROCK activity causes formation and outgrowth of processes, and breakdown of F-actin stress fibers [<xref ref-type="bibr" rid="CR34">34</xref>&#x02013;<xref ref-type="bibr" rid="CR36">36</xref>], similar to the observed effects of OXT (Fig.&#x000a0;<xref rid="Fig2" ref-type="fig">2c</xref>). In our astrocytic cultures, Gem prevented the OXT-induced activation of RhoA/ROCK (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>) and, thus, seems central for intracellular OXT effects [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR71">71</xref>]. Gem expression is facilitated by PKC [<xref ref-type="bibr" rid="CR72">72</xref>&#x02013;<xref ref-type="bibr" rid="CR74">74</xref>], which aligns with the observed PKC dependency of OXT effects on astrocytic cytoskeletal parameters and suggests that OXT regulates Gem through PKC signaling. The unique characteristics of Gem and the dependence of OXT effects on Gem highlight it as a key factor in the cell type-specific response of astrocytes to OXT.</p><p id="Par59">This is supported by the finding that Gem does not mediate OXT-induced cytoskeletal remodeling, but directly governed gap-junctional coupling, as well as Cx43 localization and phosphorylation status. The link between the cytoskeleton and GJIC is still under debate [<xref ref-type="bibr" rid="CR75">75</xref>&#x02013;<xref ref-type="bibr" rid="CR77">77</xref>]. In cultured astrocytes, ROCK-inhibition alone did not reduce GJIC [<xref ref-type="bibr" rid="CR78">78</xref>], but overexpression of Gem was sufficient to impair GJIC, suggesting that Gem controls Cx43 via inhibition of RhoA, but not ROCK. In support, direct activation of RhoA impaired GJIC in cardiac myocytes [<xref ref-type="bibr" rid="CR77">77</xref>], and Gem inhibited RhoA independently of ROCK [<xref ref-type="bibr" rid="CR69">69</xref>]. Our attempts to detect OXT-induced inhibition of RhoA activity by means of a pull-down assay of GTP-bound (i.e., active) RhoA failed due to low basal RhoA activity below detection limit; low astrocytic RhoA levels were also shown in the rat spinal cord [<xref ref-type="bibr" rid="CR79">79</xref>]. Nevertheless, even low levels of Rho GTPase expression are physiologically relevant, as introduction of constitutively active or dominant-negative RhoA or Rac1 affected astrocyte morphology [<xref ref-type="bibr" rid="CR36">36</xref>, <xref ref-type="bibr" rid="CR80">80</xref>].</p><p id="Par60">To further strengthen the link between astrocytic gap-junction proteins and cytoskeletal plasticity, we used connexin knockout mice and found that Cx43, but not Cx30, is essential for OXT-induced cytoskeletal remodeling. Cx43 has been shown to play a central role in cytoskeletal dynamics in different cell types (reviewed in [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]. Although Cx43 knockdown did not directly alter Gem, it was negatively correlated with the degree of active, i.e., phosphorylated Ezrin. pEzrin mediates Gem effects on cytoskeletal dynamics, as it interacts with Cx43, recruits Gem to the cell membrane and enables its inhibition of RhoA [<xref ref-type="bibr" rid="CR69">69</xref>]. Adapter proteins like Ezrin, which are preferentially expressed in astrocytes [<xref ref-type="bibr" rid="CR83">83</xref>], are part of Cx43 signaling scaffolds connecting Cx43 to the cytoskeleton [<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR85">85</xref>], and may link the Gem and Cx43-mediated cytoskeletal dynamics elicited by OXT. The finding of PKC-induced phosphorylation of Ezrin [<xref ref-type="bibr" rid="CR86">86</xref>] and the critical involvement of PKC-signaling in the astrocytic effects of OXT further support such a link. However, both Cx43 and Cx30 have been implicated in the regulation of cytoskeletal processes [<xref ref-type="bibr" rid="CR56">56</xref>]. Although we found that Cx30 is not required for OXT-induced astrocytic remodeling in acute hippocampal slices, it is upregulated by OXT (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>) and may compensate for the loss of Cx43-based gap-junctional coupling in vivo.</p><p id="Par61">Taken together, OXT-induced cytoskeletal remodeling of astrocytes specifically involves the connexin isoform Cx43. This is likely mediated via C-terminal interactions of Cx43 that provide a link to the cytoskeleton and do not involve its channel function. Loss of Cx43 increases the available amount of active Ezrin, a protein required for the regulatory function of Gem on the cytoskeleton.</p><p id="Par62">Investigating the underlying transcriptional mechanisms, we revealed that Sp1 drives OXT-induced expression of Gem in astrocytes. Sp1 is predominantly expressed by astrocytes [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], and Sp1 knockout impairs neuronal outgrowth and alters astrocyte morphology accompanied by cognitive deficits [<xref ref-type="bibr" rid="CR87">87</xref>]. Even though in our study knockdown of Sp1 did not produce noticeable effects (possibly due to residual Sp1 activity in the siRNA-transfected cells), OXT stimulation caused process retraction in Sp1 knockdown cells (Fig.&#x000a0;<xref rid="Fig5" ref-type="fig">5b</xref>), similar to the effects in Gem knockdown cells (Fig.&#x000a0;<xref rid="Fig3" ref-type="fig">3a, b</xref>). As OXT activated CREB in astrocytes (Fig.&#x000a0;<xref rid="Fig1" ref-type="fig">1a</xref>), and Sp1 interacts with CREB among other transcription factors [<xref ref-type="bibr" rid="CR89">89</xref>], <italic>Gem</italic> might also be regulated via such interaction. Thus, future work should validate direct binding of Sp1 to the promoter region of <italic>Gem</italic> by means of chromatin immunoprecipitation.</p><p id="Par63">Interestingly, in contrast to astrocytes, OXT downregulated Sp1 and Gem in neurons, accompanied by an increase in ROCK activity, which we found to be necessary for neurite retraction in neuronal cultured cells. Such differential and even contrary responses of neurons and astrocytes have been repeatedly described [<xref ref-type="bibr" rid="CR90">90</xref>&#x02013;<xref ref-type="bibr" rid="CR92">92</xref>]. In our in vivo experiments (Fig.&#x000a0;<xref rid="Fig6" ref-type="fig">6</xref>), two-thirds of Gem-positive cells were of astrocytic identity, which is in accordance with its preferential astrocytic expression. The differential effects of OXT on neurons and astrocytes might induce a synergistic effect on synaptic spatial relationships; on one hand astrocytes are enlarged, on the other hand neuronal structures loosen their contacts to astrocytic elements by retraction.</p><p id="Par64">Overall, we could link Sp1 to the regulation of Gem and to OXTR-coupled signaling. Thus, the previously undescribed OXTR-Sp1-Gem signaling axis could be identified as primary driver of cell type-specific OXT actions on astrocytes.</p><p id="Par65">Finally, we extend the behavioral relevance of OXTR signaling to astrocytes using astrocyte-specific OXTR shRNA or Gem shRNA vectors. In rats expressing lower levels of either OXTR or Gem specifically in astrocytes of the PVN, the local anxiolytic effect of synthetic OXT confirmed in control rats both in the EPM and LDB [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>] was abolished, which demonstrates that this effect of OXT in the hypothalamus requires direct binding to astrocytes. In support, astrocytic OXTR signalling in the rat central amygdala has recently been shown to be essential for OXT-induced reduction in pain-related anxiety [<xref ref-type="bibr" rid="CR24">24</xref>].</p><p id="Par66">In summary, by identifying astrocyte-specific signaling cascades, our study provides insights into the brain OXT system and the recruitment of astrocytes for the effects of OXT on cell morphology, cell inter-connectivity, and behaviour. While the involvement of neuronal OXTR-mediated signalling in anxiety-related and multiple other behaviors has been extensively studied [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>] the contribution of astrocytic OXT signaling has received limited attention until now [<xref ref-type="bibr" rid="CR24">24</xref>]. Thus, our work provides basic information at molecular, cellular and behavioural levels for future investigations on the mechanisms of action of OXT.</p></sec><sec id="Sec37" sec-type="supplementary-material"><title>Supplementary information</title><p>
<supplementary-material content-type="local-data" id="MOESM1"><media xlink:href="41380_2024_2870_MOESM1_ESM.png"><caption><p>FigS1</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM2"><media xlink:href="41380_2024_2870_MOESM2_ESM.png"><caption><p>FigS2</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM3"><media xlink:href="41380_2024_2870_MOESM3_ESM.png"><caption><p>FigS3</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM4"><media xlink:href="41380_2024_2870_MOESM4_ESM.png"><caption><p>FigS4</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM5"><media xlink:href="41380_2024_2870_MOESM5_ESM.png"><caption><p>FigS5</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM6"><media xlink:href="41380_2024_2870_MOESM6_ESM.png"><caption><p>FigS6</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM7"><media xlink:href="41380_2024_2870_MOESM7_ESM.png"><caption><p>FigS7</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM8"><media xlink:href="41380_2024_2870_MOESM8_ESM.png"><caption><p>FigS8</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM9"><media xlink:href="41380_2024_2870_MOESM9_ESM.docx"><caption><p>Supplementary methods and supplemental figure legends</p></caption></media></supplementary-material>
<supplementary-material content-type="local-data" id="MOESM10"><media xlink:href="41380_2024_2870_MOESM10_ESM.docx"><caption><p>Supplementary tables</p></caption></media></supplementary-material>
</p></sec></body><back><fn-group><fn><p><bold>Publisher&#x02019;s note</bold> Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn></fn-group><sec><title>Supplementary information</title><p>The online version contains supplementary material available at 10.1038/s41380-024-02870-5.</p></sec><ack><title>Acknowledgements</title><p>We would like to thank Rodrigue Maloumby, Anna K. Schmidtner, Pascal Ezan, Ramona Pawlak, Jana Nurgatina, Judith Nerb and Felix L&#x000fc;tzenkirchen for the excellent experimental support.</p></ack><notes notes-type="author-contribution"><title>Author contributions</title><p>Conceptualization CPM, IDN, NR; Methodology CPM, IDN, DM, GG, NR; Validation CPM, SP, DM, GG; Investigation CPM, SP, LB; Writing (Draft // Editing) CPM // CPM, IDN, NR, LB; Funding IDN, NR; Supervision; IDN, NR.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This work was supported by grants of the German Research Foundation (DFG) to IDN (NE465/34-1; NE465/37-1; DFG Graduate School GRK 2174), the European Research Council (consolidator grant #683154), Labex Memolife, and&#x000a0;ANR (ANR-22-CE16-0027) (to NR). Open Access funding enabled and organized by Projekt DEAL.</p></notes><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par67">The authors declare no competing interests.</p></notes><notes id="FPar2"><title>Ethics approval</title><p id="Par68">All methods performed in this study were conducted in accordance with the relevant guidelines and regulations. Ethical approval was obtained from the government of Unterfranken, and performed in accordance with EU guideline 2010/63/EU and with the regulations of the local animal welfare committee (reference number A751901). Informed consent was obtained from all participants involved in the study.</p></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group><article-title>The Oxytocin Receptor: From Intracellular Signaling to Behavior</article-title><source>Physiol Rev</source><year>2018</year><volume>98</volume><fpage>1805</fpage><lpage>908</lpage><pub-id pub-id-type="doi">10.1152/physrev.00031.2017</pub-id><pub-id pub-id-type="pmid">29897293</pub-id>
</element-citation><mixed-citation id="mc-CR1" publication-type="journal">Jurek B, Neumann ID. The Oxytocin Receptor: From Intracellular Signaling to Behavior. Physiol Rev. 2018;98:1805&#x02013;908.<pub-id pub-id-type="pmid">29897293</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name><surname>Froemke</surname><given-names>RC</given-names></name><name><surname>Young</surname><given-names>LJ</given-names></name></person-group><article-title>Oxytocin, Neural Plasticity, and Social Behavior</article-title><source>Annu Rev Neurosci</source><year>2021</year><volume>44</volume><fpage>359</fpage><lpage>81</lpage><pub-id pub-id-type="doi">10.1146/annurev-neuro-102320-102847</pub-id><pub-id pub-id-type="pmid">33823654</pub-id>
</element-citation><mixed-citation id="mc-CR2" publication-type="journal">Froemke RC, Young LJ. Oxytocin, Neural Plasticity, and Social Behavior. Annu Rev Neurosci. 2021;44:359&#x02013;81.<pub-id pub-id-type="pmid">33823654</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name><surname>Labuschagne</surname><given-names>I</given-names></name><name><surname>Phan</surname><given-names>KL</given-names></name><name><surname>Wood</surname><given-names>A</given-names></name><name><surname>Angstadt</surname><given-names>M</given-names></name><name><surname>Chua</surname><given-names>P</given-names></name><name><surname>Heinrichs</surname><given-names>M</given-names></name><etal/></person-group><article-title>Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder</article-title><source>Neuropsychopharmacology</source><year>2010</year><volume>35</volume><fpage>2403</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1038/npp.2010.123</pub-id><pub-id pub-id-type="pmid">20720535</pub-id>
</element-citation><mixed-citation id="mc-CR3" publication-type="journal">Labuschagne I, Phan KL, Wood A, Angstadt M, Chua P, Heinrichs M, et al. Oxytocin attenuates amygdala reactivity to fear in generalized social anxiety disorder. Neuropsychopharmacology. 2010;35:2403&#x02013;13.<pub-id pub-id-type="pmid">20720535</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name><surname>MacDonald</surname><given-names>K</given-names></name><name><surname>Feifel</surname><given-names>D</given-names></name></person-group><article-title>Oxytocin&#x02019;s role in anxiety: a critical appraisal</article-title><source>Brain Res</source><year>2014</year><volume>1580</volume><fpage>22</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1016/j.brainres.2014.01.025</pub-id><pub-id pub-id-type="pmid">24468203</pub-id>
</element-citation><mixed-citation id="mc-CR4" publication-type="journal">MacDonald K, Feifel D. Oxytocin&#x02019;s role in anxiety: a critical appraisal. Brain Res. 2014;1580:22&#x02013;56.<pub-id pub-id-type="pmid">24468203</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer-Lindenberg</surname><given-names>A</given-names></name><name><surname>Domes</surname><given-names>G</given-names></name><name><surname>Kirsch</surname><given-names>P</given-names></name><name><surname>Heinrichs</surname><given-names>M</given-names></name></person-group><article-title>Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine</article-title><source>Nat Rev Neurosci</source><year>2011</year><volume>12</volume><fpage>524</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1038/nrn3044</pub-id><pub-id pub-id-type="pmid">21852800</pub-id>
</element-citation><mixed-citation id="mc-CR5" publication-type="journal">Meyer-Lindenberg A, Domes G, Kirsch P, Heinrichs M. Oxytocin and vasopressin in the human brain: social neuropeptides for translational medicine. Nat Rev Neurosci. 2011;12:524&#x02013;38.<pub-id pub-id-type="pmid">21852800</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name><surname>Grinevich</surname><given-names>V</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name></person-group><article-title>Brain oxytocin: how puzzle stones from animal studies translate into psychiatry</article-title><source>Mol Psychiatry</source><year>2021</year><volume>26</volume><fpage>265</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1038/s41380-020-0802-9</pub-id><pub-id pub-id-type="pmid">32514104</pub-id>
</element-citation><mixed-citation id="mc-CR6" publication-type="journal">Grinevich V, Neumann ID. Brain oxytocin: how puzzle stones from animal studies translate into psychiatry. Mol Psychiatry. 2021;26:265&#x02013;79.<pub-id pub-id-type="pmid">32514104</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name><surname>Bakermans-Kranenburg</surname><given-names>MJ</given-names></name><name><surname>van Ijzendoorn</surname><given-names>MH</given-names></name></person-group><article-title>A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans</article-title><source>Psychiatr Genet</source><year>2014</year><volume>24</volume><fpage>45</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1097/YPG.0b013e3283643684</pub-id><pub-id pub-id-type="pmid">23921259</pub-id>
</element-citation><mixed-citation id="mc-CR7" publication-type="journal">Bakermans-Kranenburg MJ, van Ijzendoorn MH. A sociability gene? Meta-analysis of oxytocin receptor genotype effects in humans. Psychiatr Genet. 2014;24:45&#x02013;51.<pub-id pub-id-type="pmid">23921259</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name><surname>Di Scala-Guenot</surname><given-names>D</given-names></name><name><surname>Mouginot</surname><given-names>D</given-names></name><name><surname>Strosser</surname><given-names>MT</given-names></name></person-group><article-title>Increase of intracellular calcium induced by oxytocin in hypothalamic cultured astrocytes</article-title><source>Glia</source><year>1994</year><volume>11</volume><fpage>269</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1002/glia.440110308</pub-id><pub-id pub-id-type="pmid">7960031</pub-id>
</element-citation><mixed-citation id="mc-CR8" publication-type="journal">Di Scala-Guenot D, Mouginot D, Strosser MT. Increase of intracellular calcium induced by oxytocin in hypothalamic cultured astrocytes. Glia. 1994;11:269&#x02013;76.<pub-id pub-id-type="pmid">7960031</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name><surname>Mittaud</surname><given-names>P</given-names></name><name><surname>Labourdette</surname><given-names>G</given-names></name><name><surname>Zingg</surname><given-names>H</given-names></name><name><surname>Guenot-Di Scala</surname><given-names>D</given-names></name></person-group><article-title>Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-beta and membrane components</article-title><source>Glia</source><year>2002</year><volume>37</volume><fpage>169</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1002/glia.10029</pub-id><pub-id pub-id-type="pmid">11754214</pub-id>
</element-citation><mixed-citation id="mc-CR9" publication-type="journal">Mittaud P, Labourdette G, Zingg H, Guenot-Di Scala D. Neurons modulate oxytocin receptor expression in rat cultured astrocytes: involvement of TGF-beta and membrane components. Glia. 2002;37:169&#x02013;77.<pub-id pub-id-type="pmid">11754214</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name><surname>van den Burg</surname><given-names>EH</given-names></name><name><surname>Stindl</surname><given-names>J</given-names></name><name><surname>Grund</surname><given-names>T</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Strauss</surname><given-names>O</given-names></name></person-group><article-title>Oxytocin Stimulates Extracellular Ca2+ Influx Through TRPV2 Channels in Hypothalamic Neurons to Exert Its Anxiolytic Effects</article-title><source>Neuropsychopharmacology</source><year>2015</year><volume>40</volume><fpage>2938</fpage><lpage>47</lpage><pub-id pub-id-type="doi">10.1038/npp.2015.147</pub-id><pub-id pub-id-type="pmid">26013963</pub-id>
</element-citation><mixed-citation id="mc-CR10" publication-type="journal">van den Burg EH, Stindl J, Grund T, Neumann ID, Strauss O. Oxytocin Stimulates Extracellular Ca2+ Influx Through TRPV2 Channels in Hypothalamic Neurons to Exert Its Anxiolytic Effects. Neuropsychopharmacology. 2015;40:2938&#x02013;47.<pub-id pub-id-type="pmid">26013963</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name><surname>Blume</surname><given-names>A</given-names></name><name><surname>Bosch</surname><given-names>OJ</given-names></name><name><surname>Miklos</surname><given-names>S</given-names></name><name><surname>Torner</surname><given-names>L</given-names></name><name><surname>Wales</surname><given-names>L</given-names></name><name><surname>Waldherr</surname><given-names>M</given-names></name><etal/></person-group><article-title>Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus</article-title><source>Eur J Neurosci</source><year>2008</year><volume>27</volume><fpage>1947</fpage><lpage>56</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2008.06184.x</pub-id><pub-id pub-id-type="pmid">18412615</pub-id>
</element-citation><mixed-citation id="mc-CR11" publication-type="journal">Blume A, Bosch OJ, Miklos S, Torner L, Wales L, Waldherr M, et al. Oxytocin reduces anxiety via ERK1/2 activation: local effect within the rat hypothalamic paraventricular nucleus. Eur J Neurosci. 2008;27:1947&#x02013;56.<pub-id pub-id-type="pmid">18412615</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name><surname>Busnelli</surname><given-names>M</given-names></name><name><surname>Chini</surname><given-names>B</given-names></name></person-group><article-title>Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know</article-title><source>Curr Top Behav Neurosci</source><year>2018</year><volume>35</volume><fpage>3</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1007/7854_2017_6</pub-id><pub-id pub-id-type="pmid">28812263</pub-id>
</element-citation><mixed-citation id="mc-CR12" publication-type="journal">Busnelli M, Chini B. Molecular Basis of Oxytocin Receptor Signalling in the Brain: What We Know and What We Need to Know. Curr Top Behav Neurosci. 2018;35:3&#x02013;29.<pub-id pub-id-type="pmid">28812263</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name><surname>Martinetz</surname></name><name><surname>Meinung</surname><given-names>S</given-names></name><name><surname>Jurek</surname><given-names>C-P</given-names></name><name><surname>Schack</surname><given-names>B</given-names></name><name><surname>von</surname><given-names>D</given-names></name><name><surname>van den Burg</surname><given-names>EH</given-names></name><etal/></person-group><article-title>De Novo Protein Synthesis Mediated by the Eukaryotic Elongation Factor 2 Is Required for the Anxiolytic Effect of Oxytocin</article-title><source>Biol Psychiatry</source><year>2019</year><volume>85</volume><fpage>802</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.biopsych.2019.01.010</pub-id><pub-id pub-id-type="pmid">30826070</pub-id>
</element-citation><mixed-citation id="mc-CR13" publication-type="journal">Martinetz, Meinung S, Jurek C-P, Schack B, von D, van den Burg EH, et al. De Novo Protein Synthesis Mediated by the Eukaryotic Elongation Factor 2 Is Required for the Anxiolytic Effect of Oxytocin. Biol Psychiatry. 2019;85:802&#x02013;11.<pub-id pub-id-type="pmid">30826070</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name><surname>Verkhratsky</surname><given-names>A</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name></person-group><article-title>Physiology of Astroglia</article-title><source>Physiol Rev</source><year>2018</year><volume>98</volume><fpage>239</fpage><lpage>389</lpage><pub-id pub-id-type="doi">10.1152/physrev.00042.2016</pub-id><pub-id pub-id-type="pmid">29351512</pub-id>
</element-citation><mixed-citation id="mc-CR14" publication-type="journal">Verkhratsky A, Nedergaard M. Physiology of Astroglia. Physiol Rev. 2018;98:239&#x02013;389.<pub-id pub-id-type="pmid">29351512</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name><surname>Lyon</surname><given-names>KA</given-names></name><name><surname>Allen</surname><given-names>NJ</given-names></name></person-group><article-title>From Synapses to Circuits, Astrocytes Regulate Behavior</article-title><source>Front Neural Circuits</source><year>2021</year><volume>15</volume><fpage>786293</fpage><pub-id pub-id-type="doi">10.3389/fncir.2021.786293</pub-id><pub-id pub-id-type="pmid">35069124</pub-id>
</element-citation><mixed-citation id="mc-CR15" publication-type="journal">Lyon KA, Allen NJ. From Synapses to Circuits, Astrocytes Regulate Behavior. Front Neural Circuits. 2021;15:786293.<pub-id pub-id-type="pmid">35069124</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name><surname>Baudon</surname><given-names>A</given-names></name><name><surname>Clauss Creusot</surname><given-names>E</given-names></name><name><surname>Althammer</surname><given-names>F</given-names></name><name><surname>Schaaf</surname><given-names>CP</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name></person-group><article-title>Emerging role of astrocytes in oxytocin-mediated control of neural circuits and brain functions</article-title><source>Prog Neurobiol</source><year>2022</year><volume>217</volume><fpage>102328</fpage><pub-id pub-id-type="doi">10.1016/j.pneurobio.2022.102328</pub-id><pub-id pub-id-type="pmid">35870680</pub-id>
</element-citation><mixed-citation id="mc-CR16" publication-type="journal">Baudon A, Clauss Creusot E, Althammer F, Schaaf CP, Charlet A. Emerging role of astrocytes in oxytocin-mediated control of neural circuits and brain functions. Prog Neurobiol. 2022;217:102328.<pub-id pub-id-type="pmid">35870680</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name><surname>Theodosis</surname><given-names>DT</given-names></name><name><surname>Chapman</surname><given-names>DB</given-names></name><name><surname>Montagnese</surname><given-names>C</given-names></name><name><surname>Poulain</surname><given-names>DA</given-names></name><name><surname>Morris</surname><given-names>JF</given-names></name></person-group><article-title>Structural plasticity in the hypothalamic supraoptic nucleus at lactation affects oxytocin-, but not vasopressin-secreting neurones</article-title><source>Neuroscience</source><year>1986</year><volume>17</volume><fpage>661</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1016/0306-4522(86)90038-2</pub-id><pub-id pub-id-type="pmid">2422592</pub-id>
</element-citation><mixed-citation id="mc-CR17" publication-type="journal">Theodosis DT, Chapman DB, Montagnese C, Poulain DA, Morris JF. Structural plasticity in the hypothalamic supraoptic nucleus at lactation affects oxytocin-, but not vasopressin-secreting neurones. Neuroscience. 1986;17:661&#x02013;78.<pub-id pub-id-type="pmid">2422592</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name><surname>Moos</surname><given-names>F</given-names></name><name><surname>Poulain</surname><given-names>DA</given-names></name><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Guern&#x000e9;</surname><given-names>Y</given-names></name><name><surname>Vincent</surname><given-names>JD</given-names></name><name><surname>Richard</surname><given-names>P</given-names></name></person-group><article-title>Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats</article-title><source>Exp Brain Res</source><year>1989</year><volume>76</volume><fpage>593</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1007/BF00248916</pub-id><pub-id pub-id-type="pmid">2792248</pub-id>
</element-citation><mixed-citation id="mc-CR18" publication-type="journal">Moos F, Poulain DA, Rodriguez F, Guern&#x000e9; Y, Vincent JD, Richard P. Release of oxytocin within the supraoptic nucleus during the milk ejection reflex in rats. Exp Brain Res. 1989;76:593&#x02013;602.<pub-id pub-id-type="pmid">2792248</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name><surname>Oliet</surname><given-names>SH</given-names></name><name><surname>Piet</surname><given-names>R</given-names></name><name><surname>Poulain</surname><given-names>DA</given-names></name></person-group><article-title>Control of glutamate clearance and synaptic efficacy by glial coverage of neurons</article-title><source>Science</source><year>2001</year><volume>292</volume><fpage>923</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1126/science.1059162</pub-id><pub-id pub-id-type="pmid">11340204</pub-id>
</element-citation><mixed-citation id="mc-CR19" publication-type="journal">Oliet SH, Piet R, Poulain DA. Control of glutamate clearance and synaptic efficacy by glial coverage of neurons. Science. 2001;292:923&#x02013;26.<pub-id pub-id-type="pmid">11340204</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name><surname>Piet</surname><given-names>R</given-names></name><name><surname>Vargov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Sykov&#x000e1;</surname><given-names>E</given-names></name><name><surname>Poulain</surname><given-names>DA</given-names></name><name><surname>Oliet</surname><given-names>SHR</given-names></name></person-group><article-title>Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk</article-title><source>Proc Natl Acad Sci USA</source><year>2004</year><volume>101</volume><fpage>2151</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1073/pnas.0308408100</pub-id><pub-id pub-id-type="pmid">14766975</pub-id>
</element-citation><mixed-citation id="mc-CR20" publication-type="journal">Piet R, Vargov&#x000e1; L, Sykov&#x000e1; E, Poulain DA, Oliet SHR. Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. Proc Natl Acad Sci USA. 2004;101:2151&#x02013;55.<pub-id pub-id-type="pmid">14766975</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name><surname>Adamsky</surname><given-names>A</given-names></name><name><surname>Kol</surname><given-names>A</given-names></name><name><surname>Kreisel</surname><given-names>T</given-names></name><name><surname>Doron</surname><given-names>A</given-names></name><name><surname>Ozeri-Engelhard</surname><given-names>N</given-names></name><name><surname>Melcer</surname><given-names>T</given-names></name><etal/></person-group><article-title>Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement</article-title><source>Cell</source><year>2018</year><volume>174</volume><fpage>59</fpage><lpage>71.e14</lpage><pub-id pub-id-type="doi">10.1016/j.cell.2018.05.002</pub-id><pub-id pub-id-type="pmid">29804835</pub-id>
</element-citation><mixed-citation id="mc-CR21" publication-type="journal">Adamsky A, Kol A, Kreisel T, Doron A, Ozeri-Engelhard N, Melcer T, et al. Astrocytic Activation Generates De Novo Neuronal Potentiation and Memory Enhancement. Cell. 2018;174:59&#x02013;71.e14.<pub-id pub-id-type="pmid">29804835</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name><surname>Wiktorowska</surname><given-names>L</given-names></name><name><surname>Bilecki</surname><given-names>W</given-names></name><name><surname>Tertil</surname><given-names>M</given-names></name><name><surname>Kudla</surname><given-names>L</given-names></name><name><surname>Szumiec</surname><given-names>L</given-names></name><name><surname>Mackowiak</surname><given-names>M</given-names></name><etal/></person-group><article-title>Knockdown of the astrocytic glucocorticoid receptor in the central nucleus of the amygdala diminishes conditioned fear expression and anxiety</article-title><source>Behav Brain Res</source><year>2021</year><volume>402</volume><fpage>113095</fpage><pub-id pub-id-type="doi">10.1016/j.bbr.2020.113095</pub-id><pub-id pub-id-type="pmid">33359366</pub-id>
</element-citation><mixed-citation id="mc-CR22" publication-type="journal">Wiktorowska L, Bilecki W, Tertil M, Kudla L, Szumiec L, Mackowiak M, et al. Knockdown of the astrocytic glucocorticoid receptor in the central nucleus of the amygdala diminishes conditioned fear expression and anxiety. Behav Brain Res. 2021;402:113095.<pub-id pub-id-type="pmid">33359366</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name><surname>Shim</surname><given-names>HS</given-names></name><name><surname>Park</surname><given-names>HJ</given-names></name><name><surname>Woo</surname><given-names>J</given-names></name><name><surname>Lee</surname><given-names>CJ</given-names></name><name><surname>Shim</surname><given-names>I</given-names></name></person-group><article-title>Role of astrocytic GABAergic system on inflammatory cytokine-induced anxiety-like behavior</article-title><source>Neuropharmacology</source><year>2019</year><volume>160</volume><fpage>107776</fpage><pub-id pub-id-type="doi">10.1016/j.neuropharm.2019.107776</pub-id><pub-id pub-id-type="pmid">31513788</pub-id>
</element-citation><mixed-citation id="mc-CR23" publication-type="journal">Shim HS, Park HJ, Woo J, Lee CJ, Shim I. Role of astrocytic GABAergic system on inflammatory cytokine-induced anxiety-like behavior. Neuropharmacology. 2019;160:107776.<pub-id pub-id-type="pmid">31513788</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name><surname>Wahis</surname><given-names>J</given-names></name><name><surname>Baudon</surname><given-names>A</given-names></name><name><surname>Althammer</surname><given-names>F</given-names></name><name><surname>Kerspern</surname><given-names>D</given-names></name><name><surname>Goyon</surname><given-names>S</given-names></name><name><surname>Hagiwara</surname><given-names>D</given-names></name><etal/></person-group><article-title>Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents</article-title><source>Nat Neurosci</source><year>2021</year><volume>24</volume><fpage>529</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1038/s41593-021-00800-0</pub-id><pub-id pub-id-type="pmid">33589833</pub-id>
</element-citation><mixed-citation id="mc-CR24" publication-type="journal">Wahis J, Baudon A, Althammer F, Kerspern D, Goyon S, Hagiwara D, et al. Astrocytes mediate the effect of oxytocin in the central amygdala on neuronal activity and affective states in rodents. Nat Neurosci. 2021;24:529&#x02013;41.<pub-id pub-id-type="pmid">33589833</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name><surname>Schildge</surname><given-names>S</given-names></name><name><surname>Bohrer</surname><given-names>C</given-names></name><name><surname>Beck</surname><given-names>K</given-names></name><name><surname>Schachtrup</surname><given-names>C</given-names></name></person-group><article-title>Isolation and culture of mouse cortical astrocytes</article-title><source>J Vis Exp</source><year>2013</year><volume>71</volume><fpage>50079</fpage></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Schildge S, Bohrer C, Beck K, Schachtrup C. Isolation and culture of mouse cortical astrocytes. J Vis Exp. 2013;71:50079.</mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name><surname>Mugele</surname><given-names>K</given-names></name><name><surname>K&#x000fc;gler</surname><given-names>H</given-names></name><name><surname>Spiess</surname><given-names>J</given-names></name></person-group><article-title>Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA</article-title><source>DNA Cell Biol</source><year>1993</year><volume>12</volume><fpage>119</fpage><lpage>26</lpage><pub-id pub-id-type="doi">10.1089/dna.1993.12.119</pub-id><pub-id pub-id-type="pmid">8471162</pub-id>
</element-citation><mixed-citation id="mc-CR26" publication-type="journal">Mugele K, K&#x000fc;gler H, Spiess J. Immortalization of a fetal rat brain cell line that expresses corticotropin-releasing factor mRNA. DNA Cell Biol. 1993;12:119&#x02013;26.<pub-id pub-id-type="pmid">8471162</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Alfonso-Prieto</surname><given-names>M</given-names></name><name><surname>Ribeiro</surname><given-names>R</given-names></name><name><surname>Milenkovic</surname><given-names>VM</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><etal/></person-group><article-title>Structure-function relationships of the disease-linked A218T oxytocin receptor variant</article-title><source>Mol Psychiatry</source><year>2022</year><volume>27</volume><fpage>907</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1038/s41380-021-01241-8</pub-id><pub-id pub-id-type="pmid">34980886</pub-id>
</element-citation><mixed-citation id="mc-CR27" publication-type="journal">Meyer M, Jurek B, Alfonso-Prieto M, Ribeiro R, Milenkovic VM, Winter J, et al. Structure-function relationships of the disease-linked A218T oxytocin receptor variant. Mol Psychiatry. 2022;27:907&#x02013;17.<pub-id pub-id-type="pmid">34980886</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>I</given-names></name><name><surname>Royer</surname><given-names>M</given-names></name><name><surname>Bianchi</surname><given-names>M</given-names></name><name><surname>Kuffner</surname><given-names>K</given-names></name><etal/></person-group><article-title>Chronic oxytocin-driven alternative splicing of Crfr2&#x003b1; induces anxiety</article-title><source>Mol Psychiatry</source><year>2021</year><volume>11</volume><fpage>4742</fpage><lpage>55</lpage></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Winter J, Meyer M, Berger I, Royer M, Bianchi M, Kuffner K, et al. Chronic oxytocin-driven alternative splicing of Crfr2&#x003b1; induces anxiety. Mol Psychiatry. 2021;11:4742&#x02013;55.</mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name><surname>Rozental</surname><given-names>R</given-names></name><name><surname>Srinivas</surname><given-names>M</given-names></name><name><surname>Spray</surname><given-names>DC</given-names></name></person-group><article-title>How to close a gap junction channel. Efficacies and potencies of uncoupling agents</article-title><source>Methods Mol Biol</source><year>2001</year><volume>154</volume><fpage>447</fpage><lpage>76</lpage><pub-id pub-id-type="pmid">11218664</pub-id>
</element-citation><mixed-citation id="mc-CR29" publication-type="journal">Rozental R, Srinivas M, Spray DC. How to close a gap junction channel. Efficacies and potencies of uncoupling agents. Methods Mol Biol. 2001;154:447&#x02013;76.<pub-id pub-id-type="pmid">11218664</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>G</given-names></name><name><surname>Bataveljic</surname><given-names>D</given-names></name><name><surname>Visser</surname><given-names>J</given-names></name><name><surname>Kumar</surname><given-names>N</given-names></name><name><surname>Moulard</surname><given-names>J</given-names></name><name><surname>Dall&#x000e9;rac</surname><given-names>G</given-names></name><etal/></person-group><article-title>Physiological synaptic activity and recognition memory require astroglial glutamine</article-title><source>Nat Commun</source><year>2022</year><volume>13</volume><fpage>753</fpage><pub-id pub-id-type="doi">10.1038/s41467-022-28331-7</pub-id><pub-id pub-id-type="pmid">35136061</pub-id>
</element-citation><mixed-citation id="mc-CR30" publication-type="journal">Cheung G, Bataveljic D, Visser J, Kumar N, Moulard J, Dall&#x000e9;rac G, et al. Physiological synaptic activity and recognition memory require astroglial glutamine. Nat Commun. 2022;13:753.<pub-id pub-id-type="pmid">35136061</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name><surname>Penes</surname><given-names>MC</given-names></name><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Nagy</surname><given-names>JI</given-names></name></person-group><article-title>Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain</article-title><source>Eur J Neurosci</source><year>2005</year><volume>22</volume><fpage>404</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2005.04225.x</pub-id><pub-id pub-id-type="pmid">16045494</pub-id>
</element-citation><mixed-citation id="mc-CR31" publication-type="journal">Penes MC, Li X, Nagy JI. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and colocalization at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur J Neurosci. 2005;22:404&#x02013;18.<pub-id pub-id-type="pmid">16045494</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name><surname>Devost</surname><given-names>D</given-names></name><name><surname>Carrier</surname><given-names>M-E</given-names></name><name><surname>Zingg</surname><given-names>HH</given-names></name></person-group><article-title>Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C</article-title><source>Endocrinology</source><year>2008</year><volume>149</volume><fpage>131</fpage><lpage>38</lpage><pub-id pub-id-type="doi">10.1210/en.2007-0548</pub-id><pub-id pub-id-type="pmid">17947356</pub-id>
</element-citation><mixed-citation id="mc-CR32" publication-type="journal">Devost D, Carrier M-E, Zingg HH. Oxytocin-induced activation of eukaryotic elongation factor 2 in myometrial cells is mediated by protein kinase C. Endocrinology. 2008;149:131&#x02013;38.<pub-id pub-id-type="pmid">17947356</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name><surname>Upham</surname><given-names>BL</given-names></name><name><surname>Sovadinov&#x000e1;</surname><given-names>I</given-names></name><name><surname>Babica</surname><given-names>P</given-names></name></person-group><article-title>Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products</article-title><source>J Vis Exp</source><year>2016</year><volume>118</volume><fpage>54281</fpage></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Upham BL, Sovadinov&#x000e1; I, Babica P. Gap Junctional Intercellular Communication: A Functional Biomarker to Assess Adverse Effects of Toxicants and Toxins, and Health Benefits of Natural Products. J Vis Exp. 2016;118:54281.</mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name><surname>H&#x000f6;ltje</surname><given-names>M</given-names></name><name><surname>Hoffmann</surname><given-names>A</given-names></name><name><surname>Hofmann</surname><given-names>F</given-names></name><name><surname>Mucke</surname><given-names>C</given-names></name><name><surname>Grosse</surname><given-names>G</given-names></name><name><surname>van Rooijen</surname><given-names>N</given-names></name><etal/></person-group><article-title>Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing</article-title><source>J Neurochem</source><year>2005</year><volume>95</volume><fpage>1237</fpage><lpage>48</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2005.03443.x</pub-id><pub-id pub-id-type="pmid">16150054</pub-id>
</element-citation><mixed-citation id="mc-CR34" publication-type="journal">H&#x000f6;ltje M, Hoffmann A, Hofmann F, Mucke C, Grosse G, van Rooijen N, et al. Role of Rho GTPase in astrocyte morphology and migratory response during in vitro wound healing. J Neurochem. 2005;95:1237&#x02013;48.<pub-id pub-id-type="pmid">16150054</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name><surname>John</surname><given-names>GR</given-names></name><name><surname>Chen</surname><given-names>L</given-names></name><name><surname>Rivieccio</surname><given-names>MA</given-names></name><name><surname>Melendez-Vasquez</surname><given-names>CV</given-names></name><name><surname>Hartley</surname><given-names>A</given-names></name><name><surname>Brosnan</surname><given-names>CF</given-names></name></person-group><article-title>Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis</article-title><source>J Neurosci</source><year>2004</year><volume>24</volume><fpage>2837</fpage><lpage>45</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4789-03.2004</pub-id><pub-id pub-id-type="pmid">15028778</pub-id>
</element-citation><mixed-citation id="mc-CR35" publication-type="journal">John GR, Chen L, Rivieccio MA, Melendez-Vasquez CV, Hartley A, Brosnan CF. Interleukin-1beta induces a reactive astroglial phenotype via deactivation of the Rho GTPase-Rock axis. J Neurosci. 2004;24:2837&#x02013;45.<pub-id pub-id-type="pmid">15028778</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name><surname>Kalman</surname><given-names>D</given-names></name><name><surname>Gomperts</surname><given-names>SN</given-names></name><name><surname>Hardy</surname><given-names>S</given-names></name><name><surname>Kitamura</surname><given-names>M</given-names></name><name><surname>Bishop</surname><given-names>JM</given-names></name></person-group><article-title>Ras family GTPases control growth of astrocyte processes</article-title><source>Mol Biol Cell</source><year>1999</year><volume>10</volume><fpage>1665</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1091/mbc.10.5.1665</pub-id><pub-id pub-id-type="pmid">10233170</pub-id>
</element-citation><mixed-citation id="mc-CR36" publication-type="journal">Kalman D, Gomperts SN, Hardy S, Kitamura M, Bishop JM. Ras family GTPases control growth of astrocyte processes. Mol Biol Cell. 1999;10:1665&#x02013;83.<pub-id pub-id-type="pmid">10233170</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name><surname>Totsukawa</surname><given-names>G</given-names></name><name><surname>Yamakita</surname><given-names>Y</given-names></name><name><surname>Yamashiro</surname><given-names>S</given-names></name><name><surname>Hartshorne</surname><given-names>DJ</given-names></name><name><surname>Sasaki</surname><given-names>Y</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name></person-group><article-title>Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts</article-title><source>J Cell Biol</source><year>2000</year><volume>150</volume><fpage>797</fpage><lpage>806</lpage><pub-id pub-id-type="doi">10.1083/jcb.150.4.797</pub-id><pub-id pub-id-type="pmid">10953004</pub-id>
</element-citation><mixed-citation id="mc-CR37" publication-type="journal">Totsukawa G, Yamakita Y, Yamashiro S, Hartshorne DJ, Sasaki Y, Matsumura F. Distinct roles of ROCK (Rho-kinase) and MLCK in spatial regulation of MLC phosphorylation for assembly of stress fibers and focal adhesions in 3T3 fibroblasts. J Cell Biol. 2000;150:797&#x02013;806.<pub-id pub-id-type="pmid">10953004</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name><surname>Liao</surname><given-names>JK</given-names></name><name><surname>Seto</surname><given-names>M</given-names></name><name><surname>Noma</surname><given-names>K</given-names></name></person-group><article-title>Rho kinase (ROCK) inhibitors</article-title><source>J Cardiovasc Pharmacol</source><year>2007</year><volume>50</volume><fpage>17</fpage><lpage>24</lpage><pub-id pub-id-type="doi">10.1097/FJC.0b013e318070d1bd</pub-id><pub-id pub-id-type="pmid">17666911</pub-id>
</element-citation><mixed-citation id="mc-CR38" publication-type="journal">Liao JK, Seto M, Noma K. Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 2007;50:17&#x02013;24.<pub-id pub-id-type="pmid">17666911</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name><surname>Grund</surname><given-names>T</given-names></name><name><surname>Goyon</surname><given-names>S</given-names></name><name><surname>Li</surname><given-names>Y</given-names></name><name><surname>Eliava</surname><given-names>M</given-names></name><name><surname>Liu</surname><given-names>H</given-names></name><name><surname>Charlet</surname><given-names>A</given-names></name><etal/></person-group><article-title>Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis</article-title><source>J Neurosci</source><year>2017</year><volume>37</volume><fpage>12214</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.2161-17.2017</pub-id><pub-id pub-id-type="pmid">29118105</pub-id>
</element-citation><mixed-citation id="mc-CR39" publication-type="journal">Grund T, Goyon S, Li Y, Eliava M, Liu H, Charlet A, et al. Neuropeptide S Activates Paraventricular Oxytocin Neurons to Induce Anxiolysis. J Neurosci. 2017;37:12214&#x02013;25.<pub-id pub-id-type="pmid">29118105</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name><surname>Jurek</surname><given-names>B</given-names></name><name><surname>Meyer</surname><given-names>M</given-names></name></person-group><article-title>Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin</article-title><source>Front Endocrinol (Lausanne)</source><year>2020</year><volume>11</volume><fpage>186</fpage><pub-id pub-id-type="doi">10.3389/fendo.2020.00186</pub-id><pub-id pub-id-type="pmid">32322239</pub-id>
</element-citation><mixed-citation id="mc-CR40" publication-type="journal">Jurek B, Meyer M. Anxiolytic and Anxiogenic? How the Transcription Factor MEF2 Might Explain the Manifold Behavioral Effects of Oxytocin. Front Endocrinol (Lausanne). 2020;11:186.<pub-id pub-id-type="pmid">32322239</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Berger</surname><given-names>I</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name></person-group><article-title>Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A)</article-title><source>Mol Cell Endocrinol</source><year>2018</year><volume>477</volume><fpage>156</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1016/j.mce.2018.06.013</pub-id><pub-id pub-id-type="pmid">29928931</pub-id>
</element-citation><mixed-citation id="mc-CR41" publication-type="journal">Meyer M, Berger I, Winter J, Jurek B. Oxytocin alters the morphology of hypothalamic neurons via the transcription factor myocyte enhancer factor 2A (MEF-2A). Mol Cell Endocrinol. 2018;477:156&#x02013;62.<pub-id pub-id-type="pmid">29928931</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>Y-F</given-names></name><name><surname>Hatton</surname><given-names>GI</given-names></name></person-group><article-title>Interaction of extracellular signal-regulated protein kinase 1/2 with actin cytoskeleton in supraoptic oxytocin neurons and astrocytes: role in burst firing</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>13822</fpage><lpage>34</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4119-07.2007</pub-id><pub-id pub-id-type="pmid">18077694</pub-id>
</element-citation><mixed-citation id="mc-CR42" publication-type="journal">Wang Y-F, Hatton GI. Interaction of extracellular signal-regulated protein kinase 1/2 with actin cytoskeleton in supraoptic oxytocin neurons and astrocytes: role in burst firing. J Neurosci. 2007;27:13822&#x02013;34.<pub-id pub-id-type="pmid">18077694</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><citation-alternatives><element-citation id="ec-CR43" publication-type="journal"><person-group person-group-type="author"><name><surname>Klein</surname><given-names>BY</given-names></name><name><surname>Tamir</surname><given-names>H</given-names></name><name><surname>Hirschberg</surname><given-names>DL</given-names></name><name><surname>Glickstein</surname><given-names>SB</given-names></name><name><surname>Welch</surname><given-names>MG</given-names></name></person-group><article-title>Oxytocin modulates mTORC1 pathway in the gut</article-title><source>Biochem Biophys Res Commun</source><year>2013</year><volume>432</volume><fpage>466</fpage><lpage>71</lpage><pub-id pub-id-type="doi">10.1016/j.bbrc.2013.01.121</pub-id><pub-id pub-id-type="pmid">23410756</pub-id>
</element-citation><mixed-citation id="mc-CR43" publication-type="journal">Klein BY, Tamir H, Hirschberg DL, Glickstein SB, Welch MG. Oxytocin modulates mTORC1 pathway in the gut. Biochem Biophys Res Commun. 2013;432:466&#x02013;71.<pub-id pub-id-type="pmid">23410756</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name><surname>Devost</surname><given-names>D</given-names></name><name><surname>Wrzal</surname><given-names>P</given-names></name><name><surname>Zingg</surname><given-names>HH</given-names></name></person-group><article-title>Oxytocin receptor signalling</article-title><source>Prog Brain Res</source><year>2008</year><volume>170</volume><fpage>167</fpage><lpage>76</lpage><pub-id pub-id-type="doi">10.1016/S0079-6123(08)00415-9</pub-id><pub-id pub-id-type="pmid">18655881</pub-id>
</element-citation><mixed-citation id="mc-CR44" publication-type="journal">Devost D, Wrzal P, Zingg HH. Oxytocin receptor signalling. Prog Brain Res. 2008;170:167&#x02013;76.<pub-id pub-id-type="pmid">18655881</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name><surname>Tahara</surname><given-names>M</given-names></name><name><surname>Morishige</surname><given-names>K</given-names></name><name><surname>Sawada</surname><given-names>K</given-names></name><name><surname>Ikebuchi</surname><given-names>Y</given-names></name><name><surname>Kawagishi</surname><given-names>R</given-names></name><name><surname>Tasaka</surname><given-names>K</given-names></name><etal/></person-group><article-title>RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction</article-title><source>Endocrinology</source><year>2002</year><volume>143</volume><fpage>920</fpage><lpage>29</lpage><pub-id pub-id-type="doi">10.1210/endo.143.3.8696</pub-id><pub-id pub-id-type="pmid">11861513</pub-id>
</element-citation><mixed-citation id="mc-CR45" publication-type="journal">Tahara M, Morishige K, Sawada K, Ikebuchi Y, Kawagishi R, Tasaka K, et al. RhoA/Rho-kinase cascade is involved in oxytocin-induced rat uterine contraction. Endocrinology. 2002;143:920&#x02013;29.<pub-id pub-id-type="pmid">11861513</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name><surname>Fong</surname><given-names>JT</given-names></name><name><surname>Nimlamool</surname><given-names>W</given-names></name><name><surname>Falk</surname><given-names>MM</given-names></name></person-group><article-title>EGF induces efficient Cx43 gap junction endocytosis in mouse embryonic stem cell colonies via phosphorylation of Ser262, Ser279/282, and Ser368</article-title><source>FEBS Lett</source><year>2014</year><volume>588</volume><fpage>836</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1016/j.febslet.2014.01.048</pub-id><pub-id pub-id-type="pmid">24492000</pub-id>
</element-citation><mixed-citation id="mc-CR46" publication-type="journal">Fong JT, Nimlamool W, Falk MM. EGF induces efficient Cx43 gap junction endocytosis in mouse embryonic stem cell colonies via phosphorylation of Ser262, Ser279/282, and Ser368. FEBS Lett. 2014;588:836&#x02013;44.<pub-id pub-id-type="pmid">24492000</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name><surname>Nimlamool</surname><given-names>W</given-names></name><name><surname>Andrews</surname><given-names>RMK</given-names></name><name><surname>Falk</surname><given-names>MM</given-names></name></person-group><article-title>Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization</article-title><source>Mol Biol Cell</source><year>2015</year><volume>26</volume><fpage>2755</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1091/mbc.E14-06-1105</pub-id><pub-id pub-id-type="pmid">26063728</pub-id>
</element-citation><mixed-citation id="mc-CR47" publication-type="journal">Nimlamool W, Andrews RMK, Falk MM. Connexin43 phosphorylation by PKC and MAPK signals VEGF-mediated gap junction internalization. Mol Biol Cell. 2015;26:2755&#x02013;68.<pub-id pub-id-type="pmid">26063728</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>GK</given-names></name><name><surname>Cruz</surname><given-names>NF</given-names></name><name><surname>Ball</surname><given-names>KK</given-names></name><name><surname>Theus</surname><given-names>SA</given-names></name><name><surname>Dienel</surname><given-names>GA</given-names></name></person-group><article-title>Selective astrocytic gap junctional trafficking of molecules involved in the glycolytic pathway: impact on cellular brain imaging</article-title><source>J Neurochem</source><year>2009</year><volume>110</volume><fpage>857</fpage><lpage>69</lpage><pub-id pub-id-type="doi">10.1111/j.1471-4159.2009.06173.x</pub-id><pub-id pub-id-type="pmid">19457076</pub-id>
</element-citation><mixed-citation id="mc-CR48" publication-type="journal">Gandhi GK, Cruz NF, Ball KK, Theus SA, Dienel GA. Selective astrocytic gap junctional trafficking of molecules involved in the glycolytic pathway: impact on cellular brain imaging. J Neurochem. 2009;110:857&#x02013;69.<pub-id pub-id-type="pmid">19457076</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name><surname>Rouach</surname><given-names>N</given-names></name><name><surname>Koulakoff</surname><given-names>A</given-names></name><name><surname>Abudara</surname><given-names>V</given-names></name><name><surname>Willecke</surname><given-names>K</given-names></name><name><surname>Giaume</surname><given-names>C</given-names></name></person-group><article-title>Astroglial metabolic networks sustain hippocampal synaptic transmission</article-title><source>Science</source><year>2008</year><volume>322</volume><fpage>1551</fpage><lpage>55</lpage><pub-id pub-id-type="doi">10.1126/science.1164022</pub-id><pub-id pub-id-type="pmid">19056987</pub-id>
</element-citation><mixed-citation id="mc-CR49" publication-type="journal">Rouach N, Koulakoff A, Abudara V, Willecke K, Giaume C. Astroglial metabolic networks sustain hippocampal synaptic transmission. Science. 2008;322:1551&#x02013;55.<pub-id pub-id-type="pmid">19056987</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name><surname>Pannasch</surname><given-names>U</given-names></name><name><surname>Vargov&#x000e1;</surname><given-names>L</given-names></name><name><surname>Reingruber</surname><given-names>J</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><name><surname>Holcman</surname><given-names>D</given-names></name><name><surname>Giaume</surname><given-names>C</given-names></name><etal/></person-group><article-title>Astroglial networks scale synaptic activity and plasticity</article-title><source>Proc Natl Acad Sci USA</source><year>2011</year><volume>108</volume><fpage>8467</fpage><lpage>72</lpage><pub-id pub-id-type="doi">10.1073/pnas.1016650108</pub-id><pub-id pub-id-type="pmid">21536893</pub-id>
</element-citation><mixed-citation id="mc-CR50" publication-type="journal">Pannasch U, Vargov&#x000e1; L, Reingruber J, Ezan P, Holcman D, Giaume C, et al. Astroglial networks scale synaptic activity and plasticity. Proc Natl Acad Sci USA. 2011;108:8467&#x02013;72.<pub-id pub-id-type="pmid">21536893</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>N</given-names></name><name><surname>Xu</surname><given-names>J</given-names></name><name><surname>Xu</surname><given-names>Q</given-names></name><name><surname>Nedergaard</surname><given-names>M</given-names></name><name><surname>Kang</surname><given-names>J</given-names></name></person-group><article-title>Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons</article-title><source>J Neurophysiol</source><year>2005</year><volume>94</volume><fpage>4121</fpage><lpage>30</lpage><pub-id pub-id-type="doi">10.1152/jn.00448.2005</pub-id><pub-id pub-id-type="pmid">16162834</pub-id>
</element-citation><mixed-citation id="mc-CR51" publication-type="journal">Kang N, Xu J, Xu Q, Nedergaard M, Kang J. Astrocytic glutamate release-induced transient depolarization and epileptiform discharges in hippocampal CA1 pyramidal neurons. J Neurophysiol. 2005;94:4121&#x02013;30.<pub-id pub-id-type="pmid">16162834</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name><surname>Serrano</surname><given-names>A</given-names></name><name><surname>Haddjeri</surname><given-names>N</given-names></name><name><surname>Lacaille</surname><given-names>J-C</given-names></name><name><surname>Robitaille</surname><given-names>R</given-names></name></person-group><article-title>GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression</article-title><source>J Neurosci</source><year>2006</year><volume>26</volume><fpage>5370</fpage><lpage>82</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.5255-05.2006</pub-id><pub-id pub-id-type="pmid">16707789</pub-id>
</element-citation><mixed-citation id="mc-CR52" publication-type="journal">Serrano A, Haddjeri N, Lacaille J-C, Robitaille R. GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression. J Neurosci. 2006;26:5370&#x02013;82.<pub-id pub-id-type="pmid">16707789</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name><surname>Pannasch</surname><given-names>U</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><article-title>Emerging role for astroglial networks in information processing: from synapse to behavior</article-title><source>Trends Neurosci</source><year>2013</year><volume>36</volume><fpage>405</fpage><lpage>17</lpage><pub-id pub-id-type="doi">10.1016/j.tins.2013.04.004</pub-id><pub-id pub-id-type="pmid">23659852</pub-id>
</element-citation><mixed-citation id="mc-CR53" publication-type="journal">Pannasch U, Rouach N. Emerging role for astroglial networks in information processing: from synapse to behavior. Trends Neurosci. 2013;36:405&#x02013;17.<pub-id pub-id-type="pmid">23659852</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name><surname>Pannasch</surname><given-names>U</given-names></name><name><surname>Freche</surname><given-names>D</given-names></name><name><surname>Dall&#x000e9;rac</surname><given-names>G</given-names></name><name><surname>Gh&#x000e9;zali</surname><given-names>G</given-names></name><name><surname>Escartin</surname><given-names>C</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><etal/></person-group><article-title>Connexin 30 sets synaptic strength by controlling astroglial synapse invasion</article-title><source>Nat Neurosci</source><year>2014</year><volume>17</volume><fpage>549</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1038/nn.3662</pub-id><pub-id pub-id-type="pmid">24584052</pub-id>
</element-citation><mixed-citation id="mc-CR54" publication-type="journal">Pannasch U, Freche D, Dall&#x000e9;rac G, Gh&#x000e9;zali G, Escartin C, Ezan P, et al. Connexin 30 sets synaptic strength by controlling astroglial synapse invasion. Nat Neurosci. 2014;17:549&#x02013;58.<pub-id pub-id-type="pmid">24584052</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name><surname>Pannasch</surname><given-names>U</given-names></name><name><surname>Dossi</surname><given-names>E</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><name><surname>Rouach</surname><given-names>N</given-names></name></person-group><article-title>Astroglial Cx30 sustains neuronal population bursts independently of gap-junction mediated biochemical coupling</article-title><source>Glia</source><year>2019</year><volume>67</volume><fpage>1104</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1002/glia.23591</pub-id><pub-id pub-id-type="pmid">30794327</pub-id>
</element-citation><mixed-citation id="mc-CR55" publication-type="journal">Pannasch U, Dossi E, Ezan P, Rouach N. Astroglial Cx30 sustains neuronal population bursts independently of gap-junction mediated biochemical coupling. Glia. 2019;67:1104&#x02013;12.<pub-id pub-id-type="pmid">30794327</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name><surname>Gh&#x000e9;zali</surname><given-names>G</given-names></name><name><surname>Calvo</surname><given-names>C-F</given-names></name><name><surname>Pillet</surname><given-names>L-E</given-names></name><name><surname>Llense</surname><given-names>F</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><name><surname>Pannasch</surname><given-names>U</given-names></name><etal/></person-group><article-title>Connexin 30 controls astroglial polarization during postnatal brain development</article-title><source>Development</source><year>2018</year><volume>145</volume><fpage>155275</fpage><pub-id pub-id-type="doi">10.1242/dev.155275</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Gh&#x000e9;zali G, Calvo C-F, Pillet L-E, Llense F, Ezan P, Pannasch U, et al. Connexin 30 controls astroglial polarization during postnatal brain development. Development. 2018;145:155275.</mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name><surname>Reichenbach</surname><given-names>A</given-names></name><name><surname>Derouiche</surname><given-names>A</given-names></name><name><surname>Kirchhoff</surname><given-names>F</given-names></name></person-group><article-title>Morphology and dynamics of perisynaptic glia</article-title><source>Brain Res Rev</source><year>2010</year><volume>63</volume><fpage>11</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.brainresrev.2010.02.003</pub-id><pub-id pub-id-type="pmid">20176054</pub-id>
</element-citation><mixed-citation id="mc-CR57" publication-type="journal">Reichenbach A, Derouiche A, Kirchhoff F. Morphology and dynamics of perisynaptic glia. Brain Res Rev. 2010;63:11&#x02013;25.<pub-id pub-id-type="pmid">20176054</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name><surname>Heller</surname><given-names>JP</given-names></name><name><surname>Rusakov</surname><given-names>DA</given-names></name></person-group><article-title>Morphological plasticity of astroglia: Understanding synaptic microenvironment</article-title><source>Glia</source><year>2015</year><volume>63</volume><fpage>2133</fpage><lpage>51</lpage><pub-id pub-id-type="doi">10.1002/glia.22821</pub-id><pub-id pub-id-type="pmid">25782611</pub-id>
</element-citation><mixed-citation id="mc-CR58" publication-type="journal">Heller JP, Rusakov DA. Morphological plasticity of astroglia: Understanding synaptic microenvironment. Glia. 2015;63:2133&#x02013;51.<pub-id pub-id-type="pmid">25782611</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name><surname>Zeug</surname><given-names>A</given-names></name><name><surname>M&#x000fc;ller</surname><given-names>FE</given-names></name><name><surname>Anders</surname><given-names>S</given-names></name><name><surname>Herde</surname><given-names>MK</given-names></name><name><surname>Minge</surname><given-names>D</given-names></name><name><surname>Ponimaskin</surname><given-names>E</given-names></name><etal/></person-group><article-title>Control of astrocyte morphology by Rho GTPases</article-title><source>Brain Res Bull</source><year>2018</year><volume>136</volume><fpage>44</fpage><lpage>53</lpage><pub-id pub-id-type="doi">10.1016/j.brainresbull.2017.05.003</pub-id><pub-id pub-id-type="pmid">28502648</pub-id>
</element-citation><mixed-citation id="mc-CR59" publication-type="journal">Zeug A, M&#x000fc;ller FE, Anders S, Herde MK, Minge D, Ponimaskin E, et al. Control of astrocyte morphology by Rho GTPases. Brain Res Bull. 2018;136:44&#x02013;53.<pub-id pub-id-type="pmid">28502648</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><citation-alternatives><element-citation id="ec-CR60" publication-type="journal"><person-group person-group-type="author"><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Puerta</surname><given-names>F</given-names></name><name><surname>Alanazi</surname><given-names>M</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Castejon</surname><given-names>AM</given-names></name><etal/></person-group><article-title>Downregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells</article-title><source>Neurochem Res</source><year>2017</year><volume>42</volume><fpage>1006</fpage><lpage>14</lpage><pub-id pub-id-type="doi">10.1007/s11064-016-2133-4</pub-id><pub-id pub-id-type="pmid">27995495</pub-id>
</element-citation><mixed-citation id="mc-CR60" publication-type="journal">Lestanova Z, Puerta F, Alanazi M, Bacova Z, Kiss A, Castejon AM, et al. Downregulation of Oxytocin Receptor Decreases the Length of Projections Stimulated by Retinoic Acid in the U-87MG Cells. Neurochem Res. 2017;42:1006&#x02013;14.<pub-id pub-id-type="pmid">27995495</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name><surname>Ripamonti</surname><given-names>S</given-names></name><name><surname>Ambrozkiewicz</surname><given-names>MC</given-names></name><name><surname>Guzzi</surname><given-names>F</given-names></name><name><surname>Gravati</surname><given-names>M</given-names></name><name><surname>Biella</surname><given-names>G</given-names></name><name><surname>Bormuth</surname><given-names>I</given-names></name><etal/></person-group><article-title>Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons</article-title><source>Elife</source><year>2017</year><volume>6</volume><fpage>22466</fpage><pub-id pub-id-type="doi">10.7554/eLife.22466</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Ripamonti S, Ambrozkiewicz MC, Guzzi F, Gravati M, Biella G, Bormuth I, et al. Transient oxytocin signaling primes the development and function of excitatory hippocampal neurons. Elife. 2017;6:22466.</mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><citation-alternatives><element-citation id="ec-CR62" publication-type="journal"><person-group person-group-type="author"><name><surname>Meyer</surname><given-names>M</given-names></name><name><surname>Kuffner</surname><given-names>K</given-names></name><name><surname>Winter</surname><given-names>J</given-names></name><name><surname>Neumann</surname><given-names>ID</given-names></name><name><surname>Wetzel</surname><given-names>CH</given-names></name><name><surname>Jurek</surname><given-names>B</given-names></name></person-group><article-title>Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons</article-title><source>Int J Mol Sci</source><year>2020</year><volume>21</volume><fpage>2200</fpage><pub-id pub-id-type="doi">10.3390/ijms21062200</pub-id><pub-id pub-id-type="pmid">32209973</pub-id>
</element-citation><mixed-citation id="mc-CR62" publication-type="journal">Meyer M, Kuffner K, Winter J, Neumann ID, Wetzel CH, Jurek B. Myocyte Enhancer Factor 2A (MEF2A) Defines Oxytocin-Induced Morphological Effects and Regulates Mitochondrial Function in Neurons. Int J Mol Sci. 2020;21:2200.<pub-id pub-id-type="pmid">32209973</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name><surname>Theodosis</surname><given-names>DT</given-names></name><name><surname>Montagnese</surname><given-names>C</given-names></name><name><surname>Rodriguez</surname><given-names>F</given-names></name><name><surname>Vincent</surname><given-names>JD</given-names></name><name><surname>Poulain</surname><given-names>DA</given-names></name></person-group><article-title>Oxytocin induces morphological plasticity in the adult hypothalamo-neurohypophysial system</article-title><source>Nature</source><year>1986</year><volume>322</volume><fpage>738</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1038/322738a0</pub-id><pub-id pub-id-type="pmid">3748154</pub-id>
</element-citation><mixed-citation id="mc-CR63" publication-type="journal">Theodosis DT, Montagnese C, Rodriguez F, Vincent JD, Poulain DA. Oxytocin induces morphological plasticity in the adult hypothalamo-neurohypophysial system. Nature. 1986;322:738&#x02013;40.<pub-id pub-id-type="pmid">3748154</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name><surname>Perlmutter</surname><given-names>LS</given-names></name><name><surname>Tweedle</surname><given-names>CD</given-names></name><name><surname>Hatton</surname><given-names>GI</given-names></name></person-group><article-title>Neuronal/glial plasticity in the supraoptic dendritic zone in response to acute and chronic dehydration</article-title><source>Brain Res</source><year>1985</year><volume>361</volume><fpage>225</fpage><lpage>32</lpage><pub-id pub-id-type="doi">10.1016/0006-8993(85)91293-4</pub-id><pub-id pub-id-type="pmid">4084795</pub-id>
</element-citation><mixed-citation id="mc-CR64" publication-type="journal">Perlmutter LS, Tweedle CD, Hatton GI. Neuronal/glial plasticity in the supraoptic dendritic zone in response to acute and chronic dehydration. Brain Res. 1985;361:225&#x02013;32.<pub-id pub-id-type="pmid">4084795</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name><surname>Hatton</surname><given-names>GI</given-names></name></person-group><article-title>Pituicytes, glia and control of terminal secretion</article-title><source>J Exp Biol</source><year>1988</year><volume>139</volume><fpage>67</fpage><lpage>79</lpage><pub-id pub-id-type="doi">10.1242/jeb.139.1.67</pub-id><pub-id pub-id-type="pmid">3062122</pub-id>
</element-citation><mixed-citation id="mc-CR65" publication-type="journal">Hatton GI. Pituicytes, glia and control of terminal secretion. J Exp Biol. 1988;139:67&#x02013;79.<pub-id pub-id-type="pmid">3062122</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name><surname>Bakos</surname><given-names>J</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Paulikova</surname><given-names>H</given-names></name><name><surname>Krajnakova</surname><given-names>L</given-names></name><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name></person-group><article-title>Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells</article-title><source>J Mol Neurosci</source><year>2013</year><volume>50</volume><fpage>462</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1007/s12031-013-9960-4</pub-id><pub-id pub-id-type="pmid">23335033</pub-id>
</element-citation><mixed-citation id="mc-CR66" publication-type="journal">Bakos J, Strbak V, Paulikova H, Krajnakova L, Lestanova Z, Bacova Z. Oxytocin receptor ligands induce changes in cytoskeleton in neuroblastoma cells. J Mol Neurosci. 2013;50:462&#x02013;68.<pub-id pub-id-type="pmid">23335033</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name><surname>Lestanova</surname><given-names>Z</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Havranek</surname><given-names>T</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group><article-title>Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth</article-title><source>J Mol Neurosci</source><year>2016</year><volume>59</volume><fpage>184</fpage><lpage>92</lpage><pub-id pub-id-type="doi">10.1007/s12031-015-0664-9</pub-id><pub-id pub-id-type="pmid">26474566</pub-id>
</element-citation><mixed-citation id="mc-CR67" publication-type="journal">Lestanova Z, Bacova Z, Kiss A, Havranek T, Strbak V, Bakos J. Oxytocin Increases Neurite Length and Expression of Cytoskeletal Proteins Associated with Neuronal Growth. J Mol Neurosci. 2016;59:184&#x02013;92.<pub-id pub-id-type="pmid">26474566</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name><surname>Zatkova</surname><given-names>M</given-names></name><name><surname>Reichova</surname><given-names>A</given-names></name><name><surname>Bacova</surname><given-names>Z</given-names></name><name><surname>Strbak</surname><given-names>V</given-names></name><name><surname>Kiss</surname><given-names>A</given-names></name><name><surname>Bakos</surname><given-names>J</given-names></name></person-group><article-title>Neurite Outgrowth Stimulated by Oxytocin Is Modulated by Inhibition of the Calcium Voltage-Gated Channels</article-title><source>Cell Mol Neurobiol</source><year>2018</year><volume>38</volume><fpage>371</fpage><lpage>78</lpage><pub-id pub-id-type="doi">10.1007/s10571-017-0503-3</pub-id><pub-id pub-id-type="pmid">28493233</pub-id>
</element-citation><mixed-citation id="mc-CR68" publication-type="journal">Zatkova M, Reichova A, Bacova Z, Strbak V, Kiss A, Bakos J. Neurite Outgrowth Stimulated by Oxytocin Is Modulated by Inhibition of the Calcium Voltage-Gated Channels. Cell Mol Neurobiol. 2018;38:371&#x02013;78.<pub-id pub-id-type="pmid">28493233</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name><surname>Hatzoglou</surname><given-names>A</given-names></name><name><surname>Ader</surname><given-names>I</given-names></name><name><surname>Splingard</surname><given-names>A</given-names></name><name><surname>Flanders</surname><given-names>J</given-names></name><name><surname>Saade</surname><given-names>E</given-names></name><name><surname>Leroy</surname><given-names>I</given-names></name><etal/></person-group><article-title>Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway</article-title><source>Mol Biol Cell</source><year>2007</year><volume>18</volume><fpage>1242</fpage><lpage>52</lpage><pub-id pub-id-type="doi">10.1091/mbc.e06-06-0510</pub-id><pub-id pub-id-type="pmid">17267693</pub-id>
</element-citation><mixed-citation id="mc-CR69" publication-type="journal">Hatzoglou A, Ader I, Splingard A, Flanders J, Saade E, Leroy I, et al. Gem associates with Ezrin and acts via the Rho-GAP protein Gmip to down-regulate the Rho pathway. Mol Biol Cell. 2007;18:1242&#x02013;52.<pub-id pub-id-type="pmid">17267693</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>Y</given-names></name><name><surname>Yap</surname><given-names>S-F</given-names></name><name><surname>Ravichandran</surname><given-names>V</given-names></name><name><surname>Matsumura</surname><given-names>F</given-names></name><name><surname>Ito</surname><given-names>M</given-names></name><name><surname>Spinelli</surname><given-names>B</given-names></name><etal/></person-group><article-title>The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway</article-title><source>J Cell Biol</source><year>2002</year><volume>157</volume><fpage>291</fpage><lpage>302</lpage><pub-id pub-id-type="doi">10.1083/jcb.200111026</pub-id><pub-id pub-id-type="pmid">11956230</pub-id>
</element-citation><mixed-citation id="mc-CR70" publication-type="journal">Ward Y, Yap S-F, Ravichandran V, Matsumura F, Ito M, Spinelli B, et al. The GTP binding proteins Gem and Rad are negative regulators of the Rho-Rho kinase pathway. J Cell Biol. 2002;157:291&#x02013;302.<pub-id pub-id-type="pmid">11956230</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name><surname>Gogarten</surname><given-names>W</given-names></name><name><surname>Emala</surname><given-names>CW</given-names></name><name><surname>Lindeman</surname><given-names>KS</given-names></name><name><surname>Hirshman</surname><given-names>CA</given-names></name></person-group><article-title>Oxytocin and lysophosphatidic acid induce stress fiber formation in human myometrial cells via a pathway involving Rho-kinase</article-title><source>Biol Reprod</source><year>2001</year><volume>65</volume><fpage>401</fpage><lpage>06</lpage><pub-id pub-id-type="doi">10.1095/biolreprod65.2.401</pub-id><pub-id pub-id-type="pmid">11466206</pub-id>
</element-citation><mixed-citation id="mc-CR71" publication-type="journal">Gogarten W, Emala CW, Lindeman KS, Hirshman CA. Oxytocin and lysophosphatidic acid induce stress fiber formation in human myometrial cells via a pathway involving Rho-kinase. Biol Reprod. 2001;65:401&#x02013;06.<pub-id pub-id-type="pmid">11466206</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name><surname>Leone</surname><given-names>A</given-names></name><name><surname>Mitsiades</surname><given-names>N</given-names></name><name><surname>Ward</surname><given-names>Y</given-names></name><name><surname>Spinelli</surname><given-names>B</given-names></name><name><surname>Poulaki</surname><given-names>V</given-names></name><name><surname>Tsokos</surname><given-names>M</given-names></name><etal/></person-group><article-title>The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma</article-title><source>Oncogene</source><year>2001</year><volume>20</volume><fpage>3217</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1038/sj.onc.1204420</pub-id><pub-id pub-id-type="pmid">11423971</pub-id>
</element-citation><mixed-citation id="mc-CR72" publication-type="journal">Leone A, Mitsiades N, Ward Y, Spinelli B, Poulaki V, Tsokos M, et al. The Gem GTP-binding protein promotes morphological differentiation in neuroblastoma. Oncogene. 2001;20:3217&#x02013;25.<pub-id pub-id-type="pmid">11423971</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name><surname>Maguire</surname><given-names>J</given-names></name><name><surname>Santoro</surname><given-names>T</given-names></name><name><surname>Jensen</surname><given-names>P</given-names></name><name><surname>Siebenlist</surname><given-names>U</given-names></name><name><surname>Yewdell</surname><given-names>J</given-names></name><name><surname>Kelly</surname><given-names>K</given-names></name></person-group><article-title>Gem: an induced, immediate early protein belonging to the Ras family</article-title><source>Science</source><year>1994</year><volume>265</volume><fpage>241</fpage><lpage>44</lpage><pub-id pub-id-type="doi">10.1126/science.7912851</pub-id><pub-id pub-id-type="pmid">7912851</pub-id>
</element-citation><mixed-citation id="mc-CR73" publication-type="journal">Maguire J, Santoro T, Jensen P, Siebenlist U, Yewdell J, Kelly K. Gem: an induced, immediate early protein belonging to the Ras family. Science. 1994;265:241&#x02013;44.<pub-id pub-id-type="pmid">7912851</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name><surname>Ward</surname><given-names>Y</given-names></name><name><surname>Spinelli</surname><given-names>B</given-names></name><name><surname>Quon</surname><given-names>MJ</given-names></name><name><surname>Chen</surname><given-names>H</given-names></name><name><surname>Ikeda</surname><given-names>SR</given-names></name><name><surname>Kelly</surname><given-names>K</given-names></name></person-group><article-title>Phosphorylation of critical serine residues in Gem separates cytoskeletal reorganization from down-regulation of calcium channel activity</article-title><source>Mol Cell Biol</source><year>2004</year><volume>24</volume><fpage>651</fpage><lpage>61</lpage><pub-id pub-id-type="doi">10.1128/MCB.24.2.651-661.2004</pub-id><pub-id pub-id-type="pmid">14701738</pub-id>
</element-citation><mixed-citation id="mc-CR74" publication-type="journal">Ward Y, Spinelli B, Quon MJ, Chen H, Ikeda SR, Kelly K. Phosphorylation of critical serine residues in Gem separates cytoskeletal reorganization from down-regulation of calcium channel activity. Mol Cell Biol. 2004;24:651&#x02013;61.<pub-id pub-id-type="pmid">14701738</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><name><surname>Butkevich</surname><given-names>E</given-names></name><name><surname>H&#x000fc;lsmann</surname><given-names>S</given-names></name><name><surname>Wenzel</surname><given-names>D</given-names></name><name><surname>Shirao</surname><given-names>T</given-names></name><name><surname>Duden</surname><given-names>R</given-names></name><name><surname>Majoul</surname><given-names>I</given-names></name></person-group><article-title>Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton</article-title><source>Curr Biol</source><year>2004</year><volume>14</volume><fpage>650</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.1016/j.cub.2004.03.063</pub-id><pub-id pub-id-type="pmid">15084279</pub-id>
</element-citation><mixed-citation id="mc-CR75" publication-type="journal">Butkevich E, H&#x000fc;lsmann S, Wenzel D, Shirao T, Duden R, Majoul I. Drebrin is a novel connexin-43 binding partner that links gap junctions to the submembrane cytoskeleton. Curr Biol. 2004;14:650&#x02013;58.<pub-id pub-id-type="pmid">15084279</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name><surname>Smyth</surname><given-names>JW</given-names></name><name><surname>Vogan</surname><given-names>JM</given-names></name><name><surname>Buch</surname><given-names>PJ</given-names></name><name><surname>Zhang</surname><given-names>S-S</given-names></name><name><surname>Fong</surname><given-names>TS</given-names></name><name><surname>Hong</surname><given-names>T-T</given-names></name><etal/></person-group><article-title>Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane</article-title><source>Circ Res</source><year>2012</year><volume>110</volume><fpage>978</fpage><lpage>89</lpage><pub-id pub-id-type="doi">10.1161/CIRCRESAHA.111.257964</pub-id><pub-id pub-id-type="pmid">22328533</pub-id>
</element-citation><mixed-citation id="mc-CR76" publication-type="journal">Smyth JW, Vogan JM, Buch PJ, Zhang S-S, Fong TS, Hong T-T, et al. Actin cytoskeleton rest stops regulate anterograde traffic of connexin 43 vesicles to the plasma membrane. Circ Res. 2012;110:978&#x02013;89.<pub-id pub-id-type="pmid">22328533</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name><surname>Derangeon</surname><given-names>M</given-names></name><name><surname>Bourmeyster</surname><given-names>N</given-names></name><name><surname>Plaisance</surname><given-names>I</given-names></name><name><surname>Pinet-Charvet</surname><given-names>C</given-names></name><name><surname>Chen</surname><given-names>Q</given-names></name><name><surname>Duthe</surname><given-names>F</given-names></name><etal/></person-group><article-title>RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes</article-title><source>J Biol Chem</source><year>2008</year><volume>283</volume><fpage>30754</fpage><lpage>65</lpage><pub-id pub-id-type="doi">10.1074/jbc.M801556200</pub-id><pub-id pub-id-type="pmid">18667438</pub-id>
</element-citation><mixed-citation id="mc-CR77" publication-type="journal">Derangeon M, Bourmeyster N, Plaisance I, Pinet-Charvet C, Chen Q, Duthe F, et al. RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytes. J Biol Chem. 2008;283:30754&#x02013;65.<pub-id pub-id-type="pmid">18667438</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name><surname>Rouach</surname><given-names>N</given-names></name><name><surname>P&#x000e9;bay</surname><given-names>A</given-names></name><name><surname>M&#x000ea;me</surname><given-names>W</given-names></name><name><surname>Cordier</surname><given-names>J</given-names></name><name><surname>Ezan</surname><given-names>P</given-names></name><name><surname>Etienne</surname><given-names>E</given-names></name><etal/></person-group><article-title>S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK</article-title><source>Eur J Neurosci</source><year>2006</year><volume>23</volume><fpage>1453</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1111/j.1460-9568.2006.04671.x</pub-id><pub-id pub-id-type="pmid">16553609</pub-id>
</element-citation><mixed-citation id="mc-CR78" publication-type="journal">Rouach N, P&#x000e9;bay A, M&#x000ea;me W, Cordier J, Ezan P, Etienne E, et al. S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK. Eur J Neurosci. 2006;23:1453&#x02013;64.<pub-id pub-id-type="pmid">16553609</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name><surname>Erschbamer</surname><given-names>MK</given-names></name><name><surname>Hofstetter</surname><given-names>CP</given-names></name><name><surname>Olson</surname><given-names>L</given-names></name></person-group><article-title>RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury</article-title><source>J Comp Neurol</source><year>2005</year><volume>484</volume><fpage>224</fpage><lpage>33</lpage><pub-id pub-id-type="doi">10.1002/cne.20471</pub-id><pub-id pub-id-type="pmid">15736231</pub-id>
</element-citation><mixed-citation id="mc-CR79" publication-type="journal">Erschbamer MK, Hofstetter CP, Olson L. RhoA, RhoB, RhoC, Rac1, Cdc42, and Tc10 mRNA levels in spinal cord, sensory ganglia, and corticospinal tract neurons and long-lasting specific changes following spinal cord injury. J Comp Neurol. 2005;484:224&#x02013;33.<pub-id pub-id-type="pmid">15736231</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name><surname>Nishida</surname><given-names>H</given-names></name><name><surname>Okabe</surname><given-names>S</given-names></name></person-group><article-title>Direct astrocytic contacts regulate local maturation of dendritic spines</article-title><source>J Neurosci</source><year>2007</year><volume>27</volume><fpage>331</fpage><lpage>40</lpage><pub-id pub-id-type="doi">10.1523/JNEUROSCI.4466-06.2007</pub-id><pub-id pub-id-type="pmid">17215394</pub-id>
</element-citation><mixed-citation id="mc-CR80" publication-type="journal">Nishida H, Okabe S. Direct astrocytic contacts regulate local maturation of dendritic spines. J Neurosci. 2007;27:331&#x02013;40.<pub-id pub-id-type="pmid">17215394</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name><surname>Kameritsch</surname><given-names>P</given-names></name><name><surname>Pogoda</surname><given-names>K</given-names></name><name><surname>Pohl</surname><given-names>U</given-names></name></person-group><article-title>Channel-independent influence of connexin 43 on cell migration</article-title><source>Biochim Biophys Acta</source><year>2012</year><volume>1818</volume><fpage>1993</fpage><lpage>2001</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2011.11.016</pub-id><pub-id pub-id-type="pmid">22155212</pub-id>
</element-citation><mixed-citation id="mc-CR81" publication-type="journal">Kameritsch P, Pogoda K, Pohl U. Channel-independent influence of connexin 43 on cell migration. Biochim Biophys Acta. 2012;1818:1993&#x02013;2001.<pub-id pub-id-type="pmid">22155212</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuuchi</surname><given-names>L</given-names></name><name><surname>Naus</surname><given-names>CC</given-names></name></person-group><article-title>Gap junction proteins on the move: connexins, the cytoskeleton and migration</article-title><source>Biochim Biophys Acta</source><year>2013</year><volume>1828</volume><fpage>94</fpage><lpage>108</lpage><pub-id pub-id-type="doi">10.1016/j.bbamem.2012.05.014</pub-id><pub-id pub-id-type="pmid">22613178</pub-id>
</element-citation><mixed-citation id="mc-CR82" publication-type="journal">Matsuuchi L, Naus CC. Gap junction proteins on the move: connexins, the cytoskeleton and migration. Biochim Biophys Acta. 2013;1828:94&#x02013;108.<pub-id pub-id-type="pmid">22613178</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name><surname>Derouiche</surname><given-names>A</given-names></name><name><surname>Frotscher</surname><given-names>M</given-names></name></person-group><article-title>Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins</article-title><source>Glia</source><year>2001</year><volume>36</volume><fpage>330</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1002/glia.1120</pub-id><pub-id pub-id-type="pmid">11746770</pub-id>
</element-citation><mixed-citation id="mc-CR83" publication-type="journal">Derouiche A, Frotscher M. Peripheral astrocyte processes: monitoring by selective immunostaining for the actin-binding ERM proteins. Glia. 2001;36:330&#x02013;41.<pub-id pub-id-type="pmid">11746770</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name><surname>Pidoux</surname><given-names>G</given-names></name><name><surname>Gerbaud</surname><given-names>P</given-names></name><name><surname>Dompierre</surname><given-names>J</given-names></name><name><surname>Lygren</surname><given-names>B</given-names></name><name><surname>Solstad</surname><given-names>T</given-names></name><name><surname>Evain-Brion</surname><given-names>D</given-names></name><etal/></person-group><article-title>A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion</article-title><source>J Cell Sci</source><year>2014</year><volume>127</volume><fpage>4172</fpage><lpage>85</lpage><pub-id pub-id-type="pmid">25052094</pub-id>
</element-citation><mixed-citation id="mc-CR84" publication-type="journal">Pidoux G, Gerbaud P, Dompierre J, Lygren B, Solstad T, Evain-Brion D, et al. A PKA-ezrin-Cx43 signaling complex controls gap junction communication and thereby trophoblast cell fusion. J Cell Sci. 2014;127:4172&#x02013;85.<pub-id pub-id-type="pmid">25052094</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name><surname>Dukic</surname><given-names>AR</given-names></name><name><surname>Haugen</surname><given-names>LH</given-names></name><name><surname>Pidoux</surname><given-names>G</given-names></name><name><surname>Leithe</surname><given-names>E</given-names></name><name><surname>Bakke</surname><given-names>O</given-names></name><name><surname>Task&#x000e9;n</surname><given-names>K</given-names></name></person-group><article-title>A protein kinase A-ezrin complex regulates connexin 43 gap junction communication in liver epithelial cells</article-title><source>Cell Signal</source><year>2017</year><volume>32</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1016/j.cellsig.2017.01.008</pub-id><pub-id pub-id-type="pmid">28077322</pub-id>
</element-citation><mixed-citation id="mc-CR85" publication-type="journal">Dukic AR, Haugen LH, Pidoux G, Leithe E, Bakke O, Task&#x000e9;n K. A protein kinase A-ezrin complex regulates connexin 43 gap junction communication in liver epithelial cells. Cell Signal. 2017;32:1&#x02013;11.<pub-id pub-id-type="pmid">28077322</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name><surname>Ng</surname><given-names>T</given-names></name><name><surname>Parsons</surname><given-names>M</given-names></name><name><surname>Hughes</surname><given-names>WE</given-names></name><name><surname>Monypenny</surname><given-names>J</given-names></name><name><surname>Zicha</surname><given-names>D</given-names></name><name><surname>Gautreau</surname><given-names>A</given-names></name><etal/></person-group><article-title>Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility</article-title><source>EMBO J</source><year>2001</year><volume>20</volume><fpage>2723</fpage><lpage>41</lpage><pub-id pub-id-type="doi">10.1093/emboj/20.11.2723</pub-id><pub-id pub-id-type="pmid">11387207</pub-id>
</element-citation><mixed-citation id="mc-CR86" publication-type="journal">Ng T, Parsons M, Hughes WE, Monypenny J, Zicha D, Gautreau A, et al. Ezrin is a downstream effector of trafficking PKC-integrin complexes involved in the control of cell motility. EMBO J. 2001;20:2723&#x02013;41.<pub-id pub-id-type="pmid">11387207</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name><surname>Hung</surname><given-names>C-Y</given-names></name><name><surname>Hsu</surname><given-names>T-I</given-names></name><name><surname>Chuang</surname><given-names>J-Y</given-names></name><name><surname>Su</surname><given-names>T-P</given-names></name><name><surname>Chang</surname><given-names>W-C</given-names></name><name><surname>Hung</surname><given-names>J-J</given-names></name></person-group><article-title>Sp1 in Astrocyte Is Important for Neurite Outgrowth and Synaptogenesis</article-title><source>Mol Neurobiol</source><year>2020</year><volume>57</volume><fpage>261</fpage><lpage>77</lpage><pub-id pub-id-type="doi">10.1007/s12035-019-01694-7</pub-id><pub-id pub-id-type="pmid">31317491</pub-id>
</element-citation><mixed-citation id="mc-CR87" publication-type="journal">Hung C-Y, Hsu T-I, Chuang J-Y, Su T-P, Chang W-C, Hung J-J. Sp1 in Astrocyte Is Important for Neurite Outgrowth and Synaptogenesis. Mol Neurobiol. 2020;57:261&#x02013;77.<pub-id pub-id-type="pmid">31317491</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name><surname>Mao</surname><given-names>XR</given-names></name><name><surname>Moerman-Herzog</surname><given-names>AM</given-names></name><name><surname>Chen</surname><given-names>Y</given-names></name><name><surname>Barger</surname><given-names>SW</given-names></name></person-group><article-title>Unique aspects of transcriptional regulation in neurons&#x02013;nuances in NFkappaB and Sp1-related factors</article-title><source>J Neuroinflammation</source><year>2009</year><volume>6</volume><fpage>16</fpage><pub-id pub-id-type="doi">10.1186/1742-2094-6-16</pub-id><pub-id pub-id-type="pmid">19450264</pub-id>
</element-citation><mixed-citation id="mc-CR88" publication-type="journal">Mao XR, Moerman-Herzog AM, Chen Y, Barger SW. Unique aspects of transcriptional regulation in neurons&#x02013;nuances in NFkappaB and Sp1-related factors. J Neuroinflammation. 2009;6:16.<pub-id pub-id-type="pmid">19450264</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name><surname>Safe</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>K</given-names></name></person-group><article-title>Nuclear receptor-mediated transactivation through interaction with Sp proteins</article-title><source>Prog Nucleic Acid Res Mol Biol</source><year>2004</year><volume>77</volume><fpage>1</fpage><lpage>36</lpage><pub-id pub-id-type="doi">10.1016/S0079-6603(04)77001-4</pub-id><pub-id pub-id-type="pmid">15196889</pub-id>
</element-citation><mixed-citation id="mc-CR89" publication-type="journal">Safe S, Kim K. Nuclear receptor-mediated transactivation through interaction with Sp proteins. Prog Nucleic Acid Res Mol Biol. 2004;77:1&#x02013;36.<pub-id pub-id-type="pmid">15196889</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><citation-alternatives><element-citation id="ec-CR90" publication-type="journal"><person-group person-group-type="author"><name><surname>Durkee</surname><given-names>CA</given-names></name><name><surname>Covelo</surname><given-names>A</given-names></name><name><surname>Lines</surname><given-names>J</given-names></name><name><surname>Kofuji</surname><given-names>P</given-names></name><name><surname>Aguilar</surname><given-names>J</given-names></name><name><surname>Araque</surname><given-names>A</given-names></name></person-group><article-title>Gi/o protein-coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmission</article-title><source>Glia</source><year>2019</year><volume>67</volume><fpage>1076</fpage><lpage>93</lpage><pub-id pub-id-type="doi">10.1002/glia.23589</pub-id><pub-id pub-id-type="pmid">30801845</pub-id>
</element-citation><mixed-citation id="mc-CR90" publication-type="journal">Durkee CA, Covelo A, Lines J, Kofuji P, Aguilar J, Araque A. Gi/o protein-coupled receptors inhibit neurons but activate astrocytes and stimulate gliotransmission. Glia. 2019;67:1076&#x02013;93.<pub-id pub-id-type="pmid">30801845</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name><surname>Strosser</surname><given-names>MT</given-names></name><name><surname>Evrard</surname><given-names>ME</given-names></name><name><surname>Breton</surname><given-names>C</given-names></name><name><surname>Guenot-Di Scala</surname><given-names>D</given-names></name></person-group><article-title>Phorbol ester differentially regulates oxytocin receptor binding activity in hypothalamic cultured neurons and astrocytes</article-title><source>Peptides</source><year>2001</year><volume>22</volume><fpage>677</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1016/S0196-9781(01)00378-3</pub-id><pub-id pub-id-type="pmid">11311739</pub-id>
</element-citation><mixed-citation id="mc-CR91" publication-type="journal">Strosser MT, Evrard ME, Breton C, Guenot-Di Scala D. Phorbol ester differentially regulates oxytocin receptor binding activity in hypothalamic cultured neurons and astrocytes. Peptides. 2001;22:677&#x02013;83.<pub-id pub-id-type="pmid">11311739</pub-id>
</mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><citation-alternatives><element-citation id="ec-CR92" publication-type="journal"><person-group person-group-type="author"><name><surname>Pardo</surname><given-names>L</given-names></name><name><surname>Valor</surname><given-names>LM</given-names></name><name><surname>Eraso-Pichot</surname><given-names>A</given-names></name><name><surname>Barco</surname><given-names>A</given-names></name><name><surname>Golbano</surname><given-names>A</given-names></name><name><surname>Hardingham</surname><given-names>GE</given-names></name><etal/></person-group><article-title>CREB Regulates Distinct Adaptive Transcriptional Programs in Astrocytes and Neurons</article-title><source>Sci Rep</source><year>2017</year><volume>7</volume><fpage>6390</fpage><pub-id pub-id-type="doi">10.1038/s41598-017-06231-x</pub-id><pub-id pub-id-type="pmid">28743894</pub-id>
</element-citation><mixed-citation id="mc-CR92" publication-type="journal">Pardo L, Valor LM, Eraso-Pichot A, Barco A, Golbano A, Hardingham GE, et al. CREB Regulates Distinct Adaptive Transcriptional Programs in Astrocytes and Neurons. Sci Rep. 2017;7:6390.<pub-id pub-id-type="pmid">28743894</pub-id>
</mixed-citation></citation-alternatives></ref></ref-list></back></article>